Investors in Aehr Test Systems (AEHR - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 15, 2027 $2.50 Put had some of the highest implied volatility of all equity options today.
What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?Clearly, options traders are pricing in a big move for Aehr shares, but what is the fundamental picture for the company? Currently, Aehr is a Zacks Rank #3 (Hold) in the Electronics - Measuring Instruments industry that ranks in the Top 2% of our Zacks Industry Rank. Over the last 60 days, our Zacks Consensus Estimate for the current quarter has moved from 21 cents per share to 23 cents in that period.
Given the way analysts feel about Aehr right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
Aehr Test Systems (NASDAQ:AEHR – Get Free Report)’s share price traded down 6.4% during trading on Monday. The company traded as low as $80.10 and last traded at $79.2630. 301,621 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 2,458,287 shares. The stock had previously closed at $84.64.
Analysts Set New Price Targets AEHR has been the subject of a number of recent research reports. Wall Street Zen upgraded shares of Aehr Test Systems from a “sell” rating to a “hold” rating in a research note on Saturday, July 18th. Lake Street Capital reissued a “buy” rating and set a $110.00 price objective on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Weiss Ratings lowered shares of Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a research note on Wednesday, July 29th. Freedom Capital raised shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 16th. Finally, Craig Hallum reaffirmed a “buy” rating and issued a $125.00 target price on shares of Aehr Test Systems in a report on Wednesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $132.50.
Get Our Latest Research Report on AEHR
Aehr Test Systems Trading Down 7.6% The firm has a 50 day simple moving average of $98.14 and a two-hundred day simple moving average of $89.00. The company has a market capitalization of $2.56 billion, a PE ratio of -324.93 and a beta of 3.47. Insider Buying and Selling at Aehr Test Systems In related news, Director Rhea Posedel sold 5,973 shares of the stock in a transaction on Friday, August 14th. The stock was sold at an average price of $140.00, for a total transaction of $836,220.00. Following the completion of the sale, the director directly owned 381,989 shares of the company’s stock, valued at $53,478,460. This trade represents a 1.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Adil Engineer sold 15,000 shares of Aehr Test Systems stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $131.02, for a total transaction of $1,965,300.00. Following the completion of the transaction, the chief operating officer owned 46,977 shares in the company, valued at approximately $6,154,926.54. This trade represents a 24.20% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 109,475 shares of company stock valued at $13,827,160. Corporate insiders own 4.60% of the company’s stock.
Institutional Trading of Aehr Test Systems Several hedge funds have recently made changes to their positions in the company. BlackRock Inc. purchased a new stake in shares of Aehr Test Systems in the second quarter valued at about $255,476,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Aehr Test Systems during the second quarter worth about $64,433,000. AWM Investment Company Inc. purchased a new position in Aehr Test Systems during the second quarter worth about $36,004,000. Next Century Growth Investors LLC raised its holdings in Aehr Test Systems by 99.9% during the fourth quarter. Next Century Growth Investors LLC now owns 552,506 shares of the semiconductor company’s stock worth $11,155,000 after purchasing an additional 276,160 shares in the last quarter. Finally, Bard Associates Inc. purchased a new position in Aehr Test Systems during the second quarter worth about $15,072,000. Institutional investors and hedge funds own 69.69% of the company’s stock.
Aehr Test Systems Company Profile (Get Free Report)
Aehr Test Systems (NASDAQ: AEHR) develops and manufactures test and burn-in equipment used by semiconductor manufacturers. Its systems are designed to identify reliability issues and manufacturing defects in integrated circuits, including devices tested at the wafer, die, and packaged-device levels.
The company’s product portfolio includes the FOX family of test and burn-in systems, WaferPak wafer-level test fixtures, and DiePak carriers for testing individual semiconductor dies. These solutions are used in the production of silicon carbide power semiconductors, silicon photonics devices, memory products, and other advanced semiconductor components.
Founded in 1977 and headquartered in Fremont, California, Aehr Test Systems serves semiconductor manufacturers and suppliers worldwide.
Featured Articles Five stocks we like better than Aehr Test Systems China Still Dominates Rare Earths—These 3 U.S. Companies Could Benefit 3 REITs That May Win in a Higher Interest Rate Environment Broadcom’s Anthropic Bet Gets Bigger as $60 Billion Financing Raises the Stakes Insider Buying Signals Opportunity in H.B. Fuller, FocalTherics, Cardinal Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
FREMONT, CA / ACCESS Newswire / October 8, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications,today announced that it will report financial results for its first quarter of fiscal 2027 ended September 25, 2026 on Monday, November 2, 2026 following the close of the market. The Company will host a conference call and webcast at 5:00 p.m. Eastern time to discuss the results.
As previously announced, Aehr changed its fiscal year end from May to June, shifting its quarterly reporting calendar. The company's first quarter of fiscal 2027 began on June 27, 2026 and ended on September 25, 2026. Aehr's fiscal 2027 ends on June 25, 2027.
What: Aehr Test Systems first quarter fiscal 2027 financial results.
When: Monday, November 2, at 5:00 p.m. Eastern Time (2:00 p.m. PT).
Dial in Number: To access the live call, dial +1 888-506-0062 (US and Canada) or +1 973-528-0011 (International) and give the participant passcode 953740.
Webcast: To access the live webcast, please visit the investor relations section at www.aehr.com.
Call Replay: A phone replay of the call will be available approximately two hours following the end of the live call and will remain available for one week. To access the call replay, dial +1 877-481-4010 (US and Canada) or +1 919-882-2331 (International) and enter replay passcode 54635.
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer-level, singulated die, and package-level form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, advanced artificial intelligence (AI) processors, data and telecommunications infrastructure, and solid-state memory and storage, are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr's products and solutions. Aehr has developed and introduced several innovative products including the FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full-wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full-wafer contactor capable of testing wafers up to 300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. Acquired through its acquisition of Incal Technology, Inc., Aehr's new line of high-power package-level reliability/burn-in test solutions for AI semiconductor manufacturers, including its ultra-high-power Sonoma family of test solutions for AI accelerators, GPUs, and high-performance computing (HPC) processors, position Aehr within the rapidly growing AI market as a turnkey provider of reliability and testing that span from engineering to high volume production. For more information, please visit Aehr Test Systems' website at www.aehr.com.
Orders supports customer's second AI processor program on Sonoma, with production expected to ramp in calendar 2027
FREMONT, CA / ACCESS Newswire / October 7, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced approximately $6 million in follow-on production orders from its lead hyperscale customer for package-level burn-in (PLBI) of its next-generation AI processor for data center training and inference applications.
The orders include additional Sonoma™ high-power package-level test and burn-in systems, fully turnkey burn-in modules (BIMs) and device-specific sockets, as well as production software enhancements. The systems and consumables will be deployed at one of the customer's outsourced semiconductor assembly and test (OSAT) partners in Taiwan. Deliveries under the order are scheduled over the next six months.
This next-generation AI processor is the second from this customer to use Aehr's Sonoma platform for production burn-in. Following the previously announced initial production win, these orders expand the customer's capacity ahead of an expected production ramp of this second AI device in calendar 2027. The customer has indicated that this second AI processor is expected to ultimately reach production volumes exceeding those of the customer's first processor brought into production burn-in on the Sonoma platform. That first processor is already in high-volume production, with volumes expected to continue ramping significantly as additional Sonoma system capacity is deployed over the next several months.
"These follow-on production orders demonstrate the continued expansion of our relationship with this hyperscale customer and its confidence in Sonoma to support successive generations of increasingly powerful and complex AI processors," said Gayn Erickson, President and Chief Executive Officer of Aehr Test Systems. "The program is progressing from qualification and initial production systems to additional systems, consumables and software supporting the anticipated production ramp. As volumes increase, we believe there is potential for significant additional demand for Sonoma systems and device-specific consumables."
The next-generation processor requires independently controlled thermal zones within each package to achieve the operating conditions needed for effective production burn-in and early-life failure screening. Sonoma's multi-zone thermal control capabilities enable independent temperature management across different areas of a device while delivering the high current required to electrically stress the processor.
The platform also supports independent electrical test vectors and monitoring of multiple devices or functional elements within a multi-chip package. These capabilities address the differing power densities and thermal characteristics of advanced AI packages, which increasingly combine compute die, high-bandwidth memory and interface components.
"As AI processors become more complex, controlling the temperature of the package as a whole is no longer sufficient for some applications," Erickson continued. "Sonoma's ability to independently manage multiple thermal zones and electrical test functions helps customers address these challenges. We believe these capabilities will become increasingly important as AI packages continue to grow in power, size, complexity and value."
Aehr is also engaged in detailed discussions with this customer regarding reliability qualification and production burn-in requirements for future generations of higher-power, larger AI devices. These discussions include both Aehr's Sonoma package-level and FOX-XP™ wafer-level burn-in (WLBI) platforms.
"As the value of advanced AI packages increases, identifying early-life failures before expensive packaging can deliver significant economic benefits," Erickson added. "WLBI can screen die before assembly, while PLBI can stress and screen the completed device. Customers may choose either approach or use both at different stages of qualification and production, depending on their requirements."
"Our ability to support both approaches positions Aehr well as customers develop reliability strategies for future AI processors. With Sonoma supporting this customer's first processor in high-volume production and now its next-generation program, we are building a foundation for continued growth as the customer's AI roadmap advances."
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer-level, singulated die, and package-level form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, advanced artificial intelligence (AI) processors, data and telecommunications infrastructure, and solid-state memory and storage, are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr's products and solutions. Aehr has developed and introduced several innovative products including the FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full-wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full-wafer contactor capable of testing wafers up to 300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. Acquired through its acquisition of Incal Technology, Inc., Aehr's new line of high-power package-level reliability/burn-in test solutions for AI semiconductor manufacturers, including its high-power Sonoma family of test solutions for AI accelerators, GPUs, and high-performance computing (HPC) processors, position Aehr within the rapidly growing AI market as a turnkey provider of reliability and testing that span from engineering to high volume production. For more information, please visit Aehr Test Systems' website at www.aehr.com.
Safe Harbor Statement
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr's future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "going to," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," or "continue," or the negative of these words or other similar terms or expressions that concern Aehr's expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, future requirements and orders of Aehr's new and existing customers; Aehr's ability to receive orders and generate revenue in the future, as well as Aehr's beliefs regarding the factors impacting the foregoing, including the growth of the markets referred to herein; Aehr's ability to integrate Incal efficiently; and the timing and extent to which the acquisition is accretive. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr's recent Form 10-K, 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.
Key Takeaways AEHR expects fiscal 2027 revenues of $130-$150 million, implying roughly 160%-200% growth.AEHR's record effective backlog of about $100.6 million supports rising AI production requirements.Camtek's advanced packaging generated roughly 75% of second-quarter 2026 revenues. The semiconductor equipment industry is benefiting from rising AI and high-performance computing (HPC) investment, alongside growing advanced-packaging requirements. As device architectures become more sophisticated, chipmakers increasingly require specialized testing, inspection and metrology tools to support manufacturing quality and reliability.
Aehr Test Systems, Inc. (AEHR - Free Report) and Camtek Ltd. (CAMT - Free Report) both serve this specialized equipment market, but their exposure differs.Aehr is building greater AI and HPC exposure through wafer- and package-level test and burn-in solutions and has recently pointed to accelerating demand for AI-related wafer-level burn-in. Camtek, meanwhile, focuses on inspection and metrology systems used across semiconductor manufacturing, including advanced-packaging applications, giving the two companies distinct positions within the broader semiconductor capital-equipment value chain.
Let’s dive deep and closely compare the fundamentals of the two stocks to determine which one is a better bet now.
The Case for AEHRAehr entered fiscal 2027 with a much broader growth base than it had a few years ago. AI processors have emerged as the biggest driver, with reliability and production wafer-level burn-in for AI accelerators, CPUs and network processors accounting for about 71% of fiscal 2026 revenues. In the fourth quarter of fiscal 2026, its net revenues surged 33.7% year over year. The company expects fiscal 2027 revenues of $130-$150 million, or roughly 160%-200% growth, supported by a record effective backlog of about $100.6 million and rising production requirements from existing AI customers.
The opportunity is also broadening beyond Aehr’s current lead customers. A major AI processor supplier recently completed a successful FOX wafer-level burn-in benchmark and is moving toward pilot-production validation, while the lead wafer-level AI customer subsequently placed a $22 million follow-on order to expand production capacity. Aehr is simultaneously building silicon-photonics exposure as hyperscale data centers adopt faster optical interconnects, while GaN and memory represent additional longer-term opportunities. AEHR beat earnings estimates in three of the past four quarters and met once, with an average surprise of 321.9%.
Aehr is scaling capacity to support a larger revenue base without adding excessive fixed infrastructure. Sonoma systems are now shipping from a Southeast Asian contract manufacturer with capacity for more than 20 systems per month, while Fremont and Taiwan operations have also been expanded. This flexible model could help Aehr meet uneven AI-driven demand while keeping fixed costs in check.
Product development is broadening Aehr’s addressable market. The enhanced Sonoma platform supports next-generation AI processors drawing 2,000 watts or more, while the FOX roadmap is expanding into NAND flash and HBM. Aehr is also working with multiple memory suppliers on solutions for next-generation high-bandwidth memory and flash applications, which could create another growth avenue.
The Case for CAMTCamtek’s growth is increasingly tied to the build-out of advanced packaging for AI and high-performance computing. Advanced Packaging generated roughly 75% of second-quarter 2026 revenues, while year-to-date orders exceeded $600 million, with about 80% linked to advanced-packaging applications. Demand is being driven by HBM, 2.5D/3D packaging and CoWoS-like architectures.
The order profile provides visibility beyond the current year. More than half of the $600 million order intake came from OSAT customers, while more than 20% was tied to HBM players. Camtek also secured more than $105 million of multi-system orders from a tier-1 OSAT and a leading HBM manufacturer for delivery in 2027. This suggests that growth is being supported by both capacity additions and rising inspection intensity as advanced packages incorporate more dies, interconnects and increasingly demanding process steps.
CAMT is expanding its inspection and metrology reach through newer platforms. Hawk is gaining traction in HBM and other advanced-packaging applications, while Eagle G5 improves resolution, throughput and cost of ownership. Together, the two platforms generated about half of second-quarter systems revenues, while NanoProf broadens Camtek’s metrology capabilities into additional process steps.
Beyond hardware, CAMT is strengthening its software and AI capabilities. The Visual Layer acquisition strengthens Camtek’s visual-AI capabilities across its inspection and metrology offering, while new backside inspection and fluorescence technologies broaden its application reach. Photonics is also emerging as a growth area as silicon-photonics and compound-semiconductor demand expand. CAMT beat earnings estimates in three of the past four quarters and missed once, with an average surprise of 1%.
However, Camtek remains exposed to China-related risks, including intensifying competition from domestic semiconductor-equipment suppliers and evolving export controls and trade restrictions. Rising receivables and inventory needs could also increase working-capital requirements as the company scales.
How Do Estimates Compare for AEHR & CAMT?The consensus mark for AEHR’s fiscal 2027 earnings has increased by 4 cents to 74 cents per share over the past 30 days. The company reported earnings of 3 cents per share in fiscal 2026.
The Zacks Consensus Estimate for CAMT’s 2026 earnings is pegged at $3.60 per share, unchanged over the past 30 days, indicating a 10.4% increase over 2025’s reported figure.
Price Performance ComparisonIn the year-to-date period, AEHR outperformed CAMT, the broader industry and the S&P 500 Index.
Price Performance – AEHR, CAMT, Industry & S&P 500
Image Source: Zacks Investment Research
Valuation: AEHR vs. CAMTComing to the valuation story, it seems that investors are willing to pay a premium for Aehr compared to CAMT. This is reflected in AEHR’s forward 12-month price/sales (P/S) of 19.81X compared with CAMT’s 9.88X.
Image Source: Zacks Investment Research
ConclusionBoth Aehr and Camtek are positioned to benefit from rising semiconductor complexity and AI-driven investment, but their growth profiles differ. Camtek offers broader exposure to advanced packaging, HBM and inspection/metrology, supported by a strong order pipeline and expanding product portfolio. Aehr, however, is entering a sharper growth phase as AI-related wafer-level and package-level burn-in demand accelerates, backed by a record backlog and a much higher fiscal 2027 revenue growth outlook.
The combination of rapid AI-related revenue expansion, capacity scaling and additional opportunities in silicon photonics, GaN and memory gives Aehr greater earnings-growth potential. AEHR appears more compelling at present, even though both AEHR and CAMT currently carry a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Wall Street expects a year-over-year increase in earnings on higher revenues when Aehr Test Systems (AEHR - Free Report) reports results for the quarter ended August 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.11 per share in its upcoming report, which represents a year-over-year change of +1000%.
Revenues are expected to be $27.45 million, up 150.2% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 9.38% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Aehr Test Systems?For Aehr Test Systems, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +9.09%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Aehr Test Systems will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Aehr Test Systems would post a loss of$0.01 per share when it actually produced earnings of $0.11, delivering a surprise of +1,200.00%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Aehr Test Systems appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
FREMONT, CA / ACCESS Newswire / September 28, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced that President and CEO Gayn Erickson and CFO Chris Siu will be participating in the 18th Annual CEO Investor Summit being held Tuesday, October 13that the St. Regis Hotel, San Francisco, CA.
"We once again look forward to participating in this annual event and discussing with investors and shareholders Aehr's expanding role in enabling the next generation of semiconductor devices across a wide range of markets," said Mr. Erickson. "Aehr delivers complete turnkey solutions that improve the quality, reliability, and yield of semiconductors used in critical applications, including AI processors in cloud computing and data centers, silicon carbide devices in electric vehicles and charging infrastructure, gallium nitride for advanced power conversion, and silicon photonics for data centers, 5G infrastructure and optical input/output (I/O). We are seeing strong traction with AI processors in both wafer-level and package-level formats. The growing adoption of wafer-level and package-level test and burn-in across these markets is expected to be a significant growth driver for Aehr Test Systems."
The presentation material referenced by Aehr Test at the CEO Summit may be accessed on the investor relations page of the Company's website at www.aehr.com.
About the 18th Annual CEO Investor Summit 2026
The CEO Investor Summit is held annually each year during the SEMICON West industry trade show. Collectively hosted and funded by participating companies, the CEO Investor Summit features a "round-robin" format consisting of small group meetings with company management teams. During the event, investors and analysts will have the opportunity to meet with the majority of the 11 management teams during the small group meeting sessions and networking events.
Attendance at the CEO Investor Summit is by invitation only and is available solely to accredited investors and publishing research analysts. As space is limited, please RSVP early. Hosts reserve the right to limit attendance as necessary. Last day for registration is October 2, 2026.
RSVP Contacts for 18th Annual CEO Investor Summit 2026
To RSVP for the CEO Investor Summit, please visit the CEO Summit Events website or contact either of the event co-chairs:
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer-level, singulated die, and package-level form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, advanced artificial intelligence (AI) processors, data and telecommunications infrastructure, and solid-state memory and storage, are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr's products and solutions. Aehr has developed and introduced several innovative products including the FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full-wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full-wafer contactor capable of testing wafers up to 300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. Acquired through its acquisition of Incal Technology, Inc., Aehr's new line of high-power package-level reliability/burn-in test solutions for AI semiconductor manufacturers, including its ultra-high-power Sonoma family of test solutions for AI accelerators, GPUs, and high-performance computing (HPC) processors, position Aehr within the rapidly growing AI market as a turnkey provider of reliability and testing that span from engineering to high volume production. For more information, please visit Aehr Test Systems' website at www.aehr.com.
# # #
Contacts: Aehr Test Systems
Chris Siu
Chief Financial Officer
[email protected]PondelWilkinson, Inc.
Todd Kehrli or Jim Byers
Analyst/Investor Contact
(323) 468-2300
[email protected]SOURCE: Aehr Test Systems
Aehr Test Systems, Inc. is poised for strong revenue growth, driven by robust AI/data center test demand and a substantial backlog. Management guides for FY27 revenue of $130m–$150m (160%–200% y/y growth) and non-GAAP net income margins of 18%–22%. I expect Q1 results to beat consensus but am focused on backlog quality, shipment schedules, and follow-on demand validation.
Aehr Test Systems (NASDAQ:AEHR – Get Free Report) shares gapped down before the market opened on Tuesday . The stock had previously closed at $96.93, but opened at $93.96. Aehr Test Systems shares last traded at $97.2620, with a volume of 296,347 shares.
Analyst Ratings Changes Several equities research analysts have recently weighed in on AEHR shares. Freedom Capital upgraded Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 16th. Lake Street Capital restated a “buy” rating and set a $110.00 target price on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Oppenheimer started coverage on Aehr Test Systems in a research note on Thursday, September 10th. They issued an “outperform” rating and a $120.00 price target on the stock. Jefferies Financial Group initiated coverage on Aehr Test Systems in a research report on Thursday, August 13th. They issued a “buy” rating and a $175.00 price target on the stock. Finally, Weiss Ratings lowered Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a research note on Wednesday, July 29th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Aehr Test Systems presently has a consensus rating of “Moderate Buy” and an average target price of $132.50.
Read Our Latest Analysis on Aehr Test Systems
Aehr Test Systems Price Performance The stock has a market capitalization of $3.18 billion, a P/E ratio of -405.73 and a beta of 3.06. The company’s 50 day simple moving average is $94.19 and its two-hundred day simple moving average is $83.98. Insider Buying and Selling at Aehr Test Systems In other Aehr Test Systems news, Director Rhea J. Posedel sold 5,973 shares of Aehr Test Systems stock in a transaction on Friday, August 14th. The stock was sold at an average price of $140.00, for a total value of $836,220.00. Following the completion of the transaction, the director owned 381,989 shares in the company, valued at approximately $53,478,460. The trade was a 1.54% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Laura Oliphant sold 1,717 shares of the business’s stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $133.00, for a total value of $228,361.00. Following the completion of the transaction, the director directly owned 16,100 shares in the company, valued at approximately $2,141,300. This represents a 9.64% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 109,475 shares of company stock worth $13,827,160 over the last 90 days. Company insiders own 4.60% of the company’s stock.
Institutional Trading of Aehr Test Systems A number of hedge funds and other institutional investors have recently made changes to their positions in AEHR. Envestnet Asset Management Inc. bought a new position in shares of Aehr Test Systems in the second quarter valued at about $383,000. State Street Corp grew its holdings in Aehr Test Systems by 14.4% during the 2nd quarter. State Street Corp now owns 712,926 shares of the semiconductor company’s stock worth $68,484,000 after acquiring an additional 89,620 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in Aehr Test Systems by 33.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 10,480 shares of the semiconductor company’s stock valued at $1,007,000 after acquiring an additional 2,624 shares in the last quarter. Tidal Investments LLC acquired a new stake in Aehr Test Systems in the 2nd quarter valued at about $1,512,000. Finally, Engineers Gate Manager LP raised its stake in shares of Aehr Test Systems by 5.2% in the second quarter. Engineers Gate Manager LP now owns 21,542 shares of the semiconductor company’s stock worth $2,069,000 after acquiring an additional 1,069 shares during the last quarter. 69.69% of the stock is currently owned by institutional investors and hedge funds.
Aehr Test Systems Company Profile (Get Free Report)
Aehr Test Systems (NASDAQ: AEHR) develops and manufactures semiconductor test and burn-in equipment used to verify the reliability and performance of integrated circuits, wafers and packaged devices. Its systems are designed to identify defects and reliability issues before semiconductor products are shipped to customers.
The company’s product portfolio includes the FOX family of test and burn-in systems, along with wafer-level and packaged-device solutions such as WaferPak contactors and DiePak carriers.
Further Reading Five stocks we like better than Aehr Test Systems Chips to Bots: Qualcomm’s Agentic AI Breakout Ciena Fell 40%—Now One Analyst Sees 50% Upside Energy Transfer Taps the AI Power Boom Viking’s Obesity Edge May Be Staying Power, Not Weight Loss Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
Key Takeaways AEHR trades at 18.59X forward sales after a 363% 2026 surge, leaving little room for disappointment.Aehr entered fiscal 2027 with $100.6M in backlog, supporting its $130M-$150M revenue outlook.AEHR's top five customers drove roughly 70% of fiscal 2026 revenue, heightening order and execution risk. Aehr Test Systems, Inc. (AEHR - Free Report) has become a semiconductor winner in 2026, but expectations now leave little room for disappointment. Investors are weighing two possibilities. Either the market is still catching up to Aehr’s expanding role in AI-related semiconductor testing, or the share price has moved too far ahead of what the business has proved so far.
A Premium Valuation Sets a High BarAEHR currently trades at a forward 12-month price-to-sales multiple of 18.59X. That is more than three times its three-year median of 6.05X and well above the broader industry’s average of 5.43X. The gap is also clear against peers. Teradyne, Inc. (TER - Free Report) trades at 10.08X, while Cohu, Inc. (COHU - Free Report) trades at 3.86X.
The premium leaves little room for shortfalls in bookings, revenue or margins. AEHR’s Value Score of F reinforces the view that the stock is expensive on valuation measures.
Image Source: Zacks Investment Research
Wall Street Still Sees More UpsideAnalyst sentiment remains positive despite the elevated multiple. AEHR trades below the average analyst price target of $128, implying about 41.4% upside. The high target stands at $175, while the low target is $110. The wide target range highlights uncertainty over how much future growth is already priced in and whether Aehr can deliver consistently.
AEHR Stock Has Already Repriced the StoryAEHR shares have surged 363% so far this year, far outpacing the industry’s 58.2% growth and the S&P 500’s 11.5% advance. The stock has also beaten Teradyne, up 91.9%, and Cohu, up 148.2%, over the same period.
AEHR entered 2026 weighed down by weak EV-related SiC demand. Its rapid shift toward AI applications has since reshaped the market’s view of the company.
AEHR YTD Performance Vs. TER, COHU, Industry & S&P 500 Image Source: Zacks Investment Research
A Stronger Balance Sheet Supports the RampAehr ended May 29, 2026, with $116.4 million in cash and cash equivalents, up from $24.5 million a year earlier. Total liabilities stood at $27.2 million. The cash build, supported by equity financing, gives the company flexibility as it prepares for a much larger revenue base. It can fund working-capital needs and support higher production levels.
AI is Driving the Next PhaseThe clearest source of growth is AI-related semiconductor testing.Its lead wafer-level AI account is expanding production capacity, supporting demand for FOX-XP systems and WaferPak contactors, while a separate hyperscale customer is scaling package-level burn-in for custom AI processors using Sonoma systems.
Silicon photonics is opening another growth avenue as AI data centers adopt faster optical interconnects. Aehr's lead customer is increasing production, and a newer networking customer has also moved into follow-on system orders for hyperscale deployments.
Silicon carbide offers an additional source of recovery, particularly in electric vehicles, while growing AI data-center power requirements could support renewed demand for both SiC and GaN test solutions.
Aehr is also developing wafer-level burn-in opportunities in memory, including NAND and potential HBM applications. The company is working with multiple memory suppliers, although this remains an early-stage opportunity and is not yet a meaningful contributor to current guidance.
Aehr entered fiscal 2027 with $100.6 million of effective backlog, supporting visibility into its $130-$150 million revenue outlook. Subsequent AI and silicon-photonics production orders further strengthened its order pipeline.
Estimates for AEHR Point to Another Big Step UpFor fiscal 2027, the Zacks Consensus Estimate for Aehr Test Systems’ EPS is projected at 74 cents, a sharp increase from 3 cents a year ago. For fiscal 2028, the estimate is pegged at $1.54, indicating another 108.8% increase. Moreover, analysts project fiscal 2027 revenues of $140.75 million, up 181.5%, followed by $216.67 million in fiscal 2028, implying another 53.9% increase.
Aehr beat earnings estimates in three of the past four quarters and matched once, producing an average earnings surprise of 321.9%.
What Could Go WrongCustomer concentration remains a key risk for AEHR. Its five largest customers accounted for roughly 70% of fiscal 2026 revenues, leaving results exposed to shifts in production schedules or spending by a small group of customers. Given the high value of individual system orders, even modest delays or rescheduling can create significant quarterly volatility.
AEHR also remains exposed to semiconductor capital-spending cycles. AI and data-center demand is strong, but equipment spending remains uneven, and orders can shift between quarters.The company itself cautions that backlog does not necessarily translate directly into future revenues.
Execution risk has increased alongside expectations. While manufacturing capacity has been expanded, the company must convert demand into timely shipments and profitable growth while managing supplier and component constraints. After the stock’s sharp rally, setbacks in orders, deliveries or margins could trigger an outsized market reaction.
ConclusionAehr’s growth outlook has strengthened, supported by AI demand, silicon photonics, a recovering SiC business and a sizable backlog. Still, the stock’s strong run has pushed valuation to demanding levels, leaving less room for execution missteps.
Customer concentration, lumpy semiconductor spending and the need to convert backlog into profitable growth remain key risks. With strong revenue and earnings growth already reflected in expectations, the risk-reward looks more balanced at current levels. AEHR currently carries a Zacks Rank #3 (Hold), suggesting investors may want to wait for a better entry point or clearer evidence of sustained execution. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Tidal Investments LLC bought a new stake in Aehr Test Systems (NASDAQ:AEHR – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 15,737 shares of the semiconductor company’s stock, valued at approximately $1,512,000.
A number of other hedge funds and other institutional investors also recently modified their holdings of AEHR. Arizona State Retirement System boosted its stake in shares of Aehr Test Systems by 3.2% during the 2nd quarter. Arizona State Retirement System now owns 8,245 shares of the semiconductor company’s stock worth $792,000 after acquiring an additional 253 shares in the last quarter. Advocate Investing Services LLC purchased a new position in Aehr Test Systems in the 2nd quarter valued at approximately $26,000. Nykredit A S acquired a new position in Aehr Test Systems during the second quarter worth $28,000. Compagnie Lombard Odier SCmA acquired a new position in Aehr Test Systems during the second quarter worth $34,000. Finally, KBC Group NV acquired a new position in Aehr Test Systems during the first quarter worth $30,000. 69.69% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades A number of analysts have commented on the company. Craig Hallum reiterated a “buy” rating and set a $125.00 target price on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Oppenheimer assumed coverage on Aehr Test Systems in a research note on Thursday, September 10th. They set an “outperform” rating and a $120.00 price target for the company. Jefferies Financial Group started coverage on shares of Aehr Test Systems in a research report on Thursday, August 13th. They issued a “buy” rating and a $175.00 price objective on the stock. Wall Street Zen raised shares of Aehr Test Systems from a “sell” rating to a “hold” rating in a research note on Saturday, July 18th. Finally, Zacks Research downgraded shares of Aehr Test Systems from a “strong-buy” rating to a “hold” rating in a report on Monday. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $132.50.
Get Our Latest Stock Report on AEHR Aehr Test Systems Price Performance Shares of Aehr Test Systems stock opened at $90.55 on Friday. Aehr Test Systems has a 1 year low of $18.70 and a 1 year high of $147.40. The business has a 50 day moving average price of $92.43 and a 200 day moving average price of $82.44. The company has a market capitalization of $2.96 billion, a P/E ratio of -377.28 and a beta of 3.06.
Insider Activity at Aehr Test Systems In other news, Director Howard Slayen sold 20,000 shares of the business’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $108.30, for a total value of $2,166,000.00. Following the completion of the transaction, the director directly owned 146,367 shares of the company’s stock, valued at $15,851,546.10. The trade was a 12.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Adil Engineer sold 15,000 shares of the company’s stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $131.02, for a total value of $1,965,300.00. Following the completion of the sale, the chief operating officer owned 46,977 shares in the company, valued at $6,154,926.54. This represents a 24.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 109,475 shares of company stock valued at $13,827,160 in the last ninety days. 4.60% of the stock is owned by insiders.
Aehr Test Systems Company Profile (Free Report)
Aehr Test Systems (NASDAQ: AEHR) develops and manufactures semiconductor test and burn-in equipment used to verify the reliability and performance of integrated circuits, wafers and packaged devices. Its systems are designed to identify defects and reliability issues before semiconductor products are shipped to customers.
The company’s product portfolio includes the FOX family of test and burn-in systems, along with wafer-level and packaged-device solutions such as WaferPak contactors and DiePak carriers.
See Also Five stocks we like better than Aehr Test Systems Aeluma’s Selloff Could Be Setting Up Its Next Big Move Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip? The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
Key Takeaways AEHR has shifted sharply beyond EV-related SiC, with AI and other markets driving most fiscal 2026 revenues.AI processors and silicon photonics are gaining momentum, supported by new follow-on production orders.AEHR's $100.6 million backlog and $130-$150 million fiscal 2027 revenue outlook support near-term growth. Aehr Test Systems, Inc. (AEHR - Free Report) is building a broader growth story as demand expands beyond its traditional silicon carbide (SiC) exposure. Two years ago, more than 95% of its business was tied to SiC for electric vehicles (EVs). In fiscal 2026, nearly 95% of revenues came from markets outside EV-related SiC, signaling a major shift in its business mix.
AI has emerged as the biggest new contributor. AI accelerators, CPUs and network processors accounted for about 71% of fiscal 2026 revenues, while optical device test and burn-in for data-center infrastructure transceivers, chip-to-chip I/O and hard disk drives represented another 20%. The momentum has continued into fiscal 2027, with AEHR securing a $22 million follow-on order for AI processor wafer-level burn-in (WLBI) systems in August. Silicon photonics has also gained traction, with another follow-on production order received in August.
Power semiconductors provide another leg to the growth story. AEHR received roughly $8 million of new SiC WLBI orders in July as EV programs picked up. The company is also expanding into gallium nitride applications, while memory remains a longer-term opportunity spanning NAND and high-bandwidth memory (HBM).
This wider exposure could make AEHR less dependent on a single end market and help smooth its growth profile over time. The company’s $100.6 million effective backlog and $130-$150 million fiscal 2027 revenue outlook provide support for near-term growth. Still, sustaining that pace will depend on continued ramps in AI and silicon photonics, a recovery in power semiconductor demand and successful expansion into new applications.
AEHR Faces Stiff CompetitionAehr operates in a highly competitive semiconductor test equipment market, contending with strong rivals such as Teradyne, Inc. (TER - Free Report) and FormFactor, Inc. (FORM - Free Report) .
Teradyne is benefiting from the AI-led expansion in semiconductor testing, with its Semiconductor Test business gaining from rising demand for advanced compute and memory chips. HBM, DRAM and NAND testing are emerging as key growth drivers, strengthening TER’s position in the expanding AI test market.
FormFactor is benefiting from rising testing requirements for AI and HBM, particularly through its probe card business. Strong demand for DRAM and Foundry & Logic applications is supporting growth as AI workloads drive greater complexity and testing intensity across advanced semiconductors.
AEHR’s Share Price Performance, Valuation & EstimatesAEHR’s shares have surged 152.6% over the past six months, outperforming the broader industry’s 17.3% growth.
Image Source: Zacks Investment Research
Aehr shares are trading at a premium. On a forward 12-month price-to-sales (P/S) basis, AEHR trades at 19.05X, higher than the industry’s 5.72X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for AEHR’s fiscal 2027 earnings is pegged at 74 cents per share, a sharp increase from 3 cents a year ago.
Image Source: Zacks Investment Research
Aehr currently carries a Zacks Rank#2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
On September 09, 2026, Aehr Test Systems AEHR shares rose 5.3% to $95.56, marking a notable rebound in the context of a 52-week range of $18.70 to $147.40. The stock has exhibited a year-to-date increase of 373.3%, though it has faced a 7.3% decline over the past month.
GF Value™ verdict: Current price significantly exceeds GF Value at $13.46, indicating a 610.0% overvaluation. GF Score™: 64/100, suggesting above-average overall performance. Most notable signal: Insider activity shows that insiders sold $62.7M worth of shares over the past 12 months with no buying activity. Is AEHR Overvalued or Undervalued? Aehr Test Systems AEHR presents a challenging valuation scenario primarily due to its unprofitability and cash flow negativity. The current price of $95.56 stands in stark contrast to the GF Value™ estimate of $13.46, putting the stock at a staggering 610.0% overvalued according to this proprietary intrinsic-value calculation. GF Value™ is derived from historical trading multiples, past business growth, and future performance estimates, providing a directional warning rather than a precise valuation target, especially for a company not generating profits.
The significant overvaluation risk is underscored by the fact that Aehr has been unprofitable, making traditional earnings-based valuation metrics like Price-to-Earnings (P/E) less applicable. Instead, the Price-to-Sales (P/S) ratio, which historically hovers around 4.7x for the company, becomes a more relevant measure. Given that AEHR is currently trading well above this historical median, caution is warranted for potential investors.
How Does AEHR's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 126.1x 39.7x The current forward P/E of 126.1x starkly contrasts with the 5-year median P/E of 39.7x, indicating that AEHR is trading significantly above its historical valuation. This analysis aligns with the GF Value™ indication of significant overvaluation, reinforcing the notion that AEHR's current market price is not justified by its earnings potential.
What Does AEHR's GF Score™ Tell Us? The GF Score™ is a composite score that evaluates a stock based on various factors including financial strength, profitability, growth potential, valuation, and momentum. With a GF Score™ of 64/100, AEHR is considered above average overall, but the score reveals a mixed picture when examining its sub-ranks.
Metric Rating GF Score™ 64 Financial Strength 7/10 Profitability 4/10 Growth 7/10 Valuation 1/10 Momentum 6/10 Aehr's strongest area is its financial strength, rated 7/10, indicating a solid balance sheet. However, the valuation rank of 1/10 is a stark weakness, aligning with the earlier findings of significant overvaluation. The mixed scores suggest that while the company has growth potential and reasonable financial health, its current price is not supported by its valuation metrics.
What Are Gurus and Insiders Doing with AEHR? Currently, six gurus hold shares of AEHR, with three increasing their positions and four trimming their stakes in recent quarters. This mixed activity from professional investors indicates a cautious sentiment surrounding the stock. Insider selling, amounting to $62.7M over the past 12 months without any buying, raises further concerns regarding management's confidence in the company's future prospects.
The pattern of insider selling, coupled with the mixed signals from guru activity, suggests that while there may be some confidence from certain investors, the prevailing trend among insiders points to a lack of bullish sentiment on AEHR's current market valuation.
What This Means for Investors In conclusion, Aehr Test Systems AEHR appears significantly overvalued at its current price of $95.56, especially when compared to the GF Value™ estimate of $13.46. The reliance on historical Price-to-Sales ratios rather than earnings-based metrics further underscores the caution needed when considering investment in AEHR. Investors should approach this stock with an awareness of the significant overvaluation risk and the mixed signals from both insiders and gurus.
For a deeper analysis, you can visit the Aehr Test Systems AEHR stock page and explore further details about its valuation and performance.
Frequently Asked Questions What is AEHR's GF Score™?
AEHR has a GF Score™ of 64/100, indicating an above-average overall performance in terms of its financial metrics and growth potential.
Is AEHR overvalued or undervalued?
AEHR is considered significantly overvalued, with a GF Value™ estimate of $13.46 compared to its current price of $95.56.
What is AEHR's P/E ratio?
The current forward P/E ratio for AEHR is 126.1x, which is substantially higher than its historical 5-year median P/E of 39.7x, indicating a significant overvaluation.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Disclosures I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.
Key Takeaways AEHR secured $22 million and $41 million in AI-related orders as processor testing demand expands.AEHR is broadening its AI exposure through another processor supplier and a hyperscale customer.AEHR expects fiscal 2027 revenue of $130 million-$150 million as AI testing production ramps up. Aehr Test Systems, Inc. (AEHR - Free Report) is gaining traction in AI semiconductor testing as AI chips become more complex and costly. Its wafer-level burn-in technology allows manufacturers to screen devices before packaging, helping identify early-life failures while protecting costly components and advanced substrates. This is becoming increasingly relevant as AI infrastructure scales and processors enter high-volume production.
The opportunity is already translating into orders. In August 2026, AEHR received a $22 million follow-on order from its lead AI processor customer for FOX-XP wafer-level burn-in systems, with shipments expected within six months. The order followed a $14 million purchase in February, adding to earlier production momentum and reflecting the relationship’s move toward sustained production and broader deployment.
AEHR is also broadening its AI exposure beyond one customer. The company has reported successful wafer-level benchmark results with another major AI processor supplier, which is evaluating pilot production and an additional device. Its Sonoma platform is being deployed for package-level burn-in of high-power AI processors. In April, AEHR secured a record $41 million order from a hyperscale customer for custom AI ASIC burn-in.
The opportunity lies in turning these initial wins into recurring systems, WaferPak contactors and burn-in consumables as AI processor volumes expand. AEHR expects fiscal 2027 revenues of $130 million to $150 million, representing 2.6 to 3 times fiscal 2026 revenues. The company’s AI customer base is still developing, but follow-on orders and expanding production ramps suggest AI testing could evolve from a growth area into a durable revenue stream for AEHR.
AEHR Faces Stiff CompetitionAehr operates in a highly competitive semiconductor test equipment market, contending with strong rivals such as Teradyne, Inc. (TER - Free Report) and FormFactor, Inc. (FORM - Free Report) .
Teradyne is benefiting from strong AI-driven demand across compute and memory testing. TER reported Semiconductor Test revenues of $2.2 billion in the first half of 2026, supported by hyperscaler and AI infrastructure spending, while high-bandwidth memory (HBM) and DRAM testing add another growth avenue.
FormFactor is expanding its role in AI semiconductor testing through advanced probe cards and test solutions for HBM, advanced packaging and silicon photonics. Rising AI chip complexity is increasing test requirements, supporting demand for FORM’s precision testing capabilities across next-generation computing architectures.
AEHR’s Share Price Performance, Valuation & EstimatesAEHR’s shares have surged 111% over the past six months, outperforming the broader industry’s 14.3% growth.
Image Source: Zacks Investment Research
Aehr shares are trading at a premium. In terms of the forward 12-month price-to-sales (P/S), AEHR is trading at 17.51X, higher than the industry’s 5.54X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for AEHR’s fiscal 2027 earnings is pegged at 70 cents per share, a sharp increase from 3 cents a year ago.
Image Source: Zacks Investment Research
Aehr currently carries a Zacks Rank#2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
For those looking to find strong Computer and Technology stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Aehr Test Systems (AEHR - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Computer and Technology sector should help us answer this question.
Aehr Test Systems is one of 613 companies in the Computer and Technology group. The Computer and Technology group currently sits at #3 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Aehr Test Systems is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for AEHR's full-year earnings has moved 1350% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that AEHR has returned about 327.2% since the start of the calendar year. At the same time, Computer and Technology stocks have gained an average of 17.9%. This means that Aehr Test Systems is performing better than its sector in terms of year-to-date returns.
Another stock in the Computer and Technology sector, Fortinet (FTNT - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 96.8%.
For Fortinet, the consensus EPS estimate for the current year has increased 9.6% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).
Breaking things down more, Aehr Test Systems is a member of the Electronics - Measuring Instruments industry, which includes 5 individual companies and currently sits at #30 in the Zacks Industry Rank. This group has gained an average of 60.4% so far this year, so AEHR is performing better in this area.
In contrast, Fortinet falls under the Security industry. Currently, this industry has 9 stocks and is ranked #76. Since the beginning of the year, the industry has moved +71.8%.
Going forward, investors interested in Computer and Technology stocks should continue to pay close attention to Aehr Test Systems and Fortinet as they could maintain their solid performance.
FREMONT, CA / ACCESS Newswire / September 3, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced that President and CEO Gayn Erickson and CFO Chris Siu will be participating in meetings with institutional investors at the Lake Street Capital Markets 10th Annual Best Ideas Growth Conference taking place Thursday, September 10, 2026 at the Metropolitan Club in New York City.
"We look forward to discussing with investors and shareholders Aehr's expanding role in enabling the next generation of semiconductor devices across a wide range of markets," said Mr. Erickson. "Aehr delivers complete turnkey solutions that improve the quality, reliability, and yield of semiconductors used in critical applications, including AI processors in cloud computing and data centers, silicon carbide devices in electric vehicles and charging infrastructure, gallium nitride for advanced power conversion, and silicon photonics for data centers, 5G infrastructure and optical input/output (I/O). We are seeing strong traction with AI processors in both wafer-level and package-level formats. The growing adoption of wafer-level and package-level test and burn-in across these markets is expected to be a significant growth driver for Aehr Test Systems."
For additional information or to schedule a meeting with Aehr management, please contact your Lake Street Capital Markets representative or Aehr's investor relations firm, PondelWilkinson, Inc., at [email protected].
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer-level, singulated die, and package-level form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, advanced artificial intelligence (AI) processors, data and telecommunications infrastructure, and solid-state memory and storage, are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr's products and solutions. Aehr has developed and introduced several innovative products including the FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full-wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full-wafer contactor capable of testing wafers up to 300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. Acquired through its acquisition of Incal Technology, Inc., Aehr's new line of high-power package-level reliability/burn-in test solutions for AI semiconductor manufacturers, including its ultra-high-power Sonoma family of test solutions for AI accelerators, GPUs, and high-performance computing (HPC) processors, position Aehr within the rapidly growing AI market as a turnkey provider of reliability and testing that span from engineering to high volume production. For more information, please visit Aehr Test Systems' website at www.aehr.com.
Bank of New York Mellon Corp purchased a new stake in Aehr Test Systems (NASDAQ: AEHR) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 93,571 shares of the semiconductor company's stock, valued at approximately $8,988,000. Bank of
Vernon Rogers, Exec VP of Sales & Mktg. at Aehr Test Systems(AEHR -2.10%), sold 5,994 shares of common stock at $141.34 per share, according to a recent SEC Form 4 filing.
Transaction summaryMetricValueShares sold (directly held)5,994Transaction value$847,192Post-transaction shares (directly held)186,232Post-transaction value$27.1 millionTransaction value based on SEC Form 4 weighted average sale price ($141.34); post-transaction value based on Aug. 17, 2026, market close ($145.61).
Key questionsHow does this transaction affect the executive's overall equity exposure?
The sale was a marginal adjustment to the insider's position, reducing direct holdings by 3% while retaining 186,232 shares with a market value exceeding $27 million.In what performance environment did this sale take place?
The executive disposed of shares after the stock experienced significant appreciation, marked by a 695% return in the 12 months preceding the Aug. 17, 2026, market close.What is the nature of the remaining equity stake?
The remaining 186,232 shares include unvested restricted stock units, which ensure the executive remains aligned with long-term shareholder interests despite the recent liquidity event.Company OverviewMetricValueShare Price (as of market close 2026-08-17)$145.61Market Capitalization$2.5 billionRevenue (TTM)$50 millionNet Income (TTM)-$7.1 millionCompany SnapshotAehr Test Systems designs and manufactures advanced burn-in and test systems for integrated circuits, including logic, optical, and memory devices, with primary revenue derived from its ABTS and FOX-P families of test and burn-in solutions.The company generates revenue through the sale of specialized semiconductor test equipment and complementary components such as the FOX WaferPak Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier, and FOX DiePak Loader to semiconductor manufacturers and test service providers.Aehr Test Systems serves global semiconductor manufacturers and contract test service providers that require advanced burn-in and test capabilities to validate integrated circuit performance and reliability across multiple device types.Aehr Test Systems, founded in 1977 and headquartered in Fremont, California, is a specialized provider of critical test and burn-in equipment for the semiconductor industry. The company employs 138 people and maintains a focused market position serving semiconductor manufacturers that require advanced validation solutions for integrated circuits. With a market capitalization of $2.5 billion as of Aug. 31, 2026, Aehr has demonstrated significant investor interest in its specialized semiconductor test equipment offerings. However, the company remains in a pre-profitability phase with TTM net losses of $7.1 million against TTM revenues of $50 million.
Premium Feature
Moneyball Superscore
70/100
Today's Change
(
-2.10
%) $
-1.70
Current Price
$
79.11
What this transaction means for investorsAehr Test Systems is at the right place at the right time for the artificial intelligence (AI) boom. According to Statista, the global AI market is expected to reach $617.6 billion in value in 2026 and $1.4 trillion by 2032. Demand is showing up in the company's earnings, as it reported $18.8 million in net revenue for its fiscal four quarter of 2026, an increase from the $14.1 million reported in the year-ago period. Aehr also reported net income of $1.4 million for the quarter, a notable improvement over the $2.9 million net loss from the fourth quarter of 2025. Bookings also hit a record $60.7 million for the quarter, and as of May 29, Aehr Test Systems has a backlog of $80.6 million.
Just thus far in 2026, the stock price has climbed 291.4%. In comparison, the S&P 500 is up 12.1% in the same period. With that context in mind, and given the nearly 6,000 shares sold Rogers sold, this transaction appears to be largely a routine sale. This is likely a situation of the executive just taking some profits off the table, as he still owns 186,232 worth of stock. If more shares were sold, that might be more noteworthy, but for shareholders, this doesn't appear to signal any concern about the company's future.
Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Key Takeaways AEHR's AI processor orders and diversification are driving a stronger growth profile.AEHR expects fiscal 2027 revenues of $130 million to $150 million, up 2.6 to 3 times fiscal 2026 levels.COHU is expanding in HPC, HBM inspection, power semiconductors and software analytics. The semiconductor equipment industry is evolving alongside rising chip complexity, advanced packaging requirements and growing demand for specialized testing solutions. These trends are increasing the importance of efficient test and inspection capabilities across the semiconductor manufacturing cycle while also creating varied growth opportunities for equipment providers.
Aehr Test Systems, Inc. (AEHR - Free Report) and Cohu, Inc. (COHU - Free Report) both serve the semiconductor testing market but differ in their product portfolios, customer exposure and growth strategies. AEHR has a more focused presence in wafer-level and burn-in test solutions, while COHU offers a broader range of semiconductor test and handling equipment. Their differing business mixes and strategic priorities provide a useful basis for comparing fundamentals, growth durability and long-term prospects.
Let’s dive deep and closely compare the fundamentals of the two stocks to determine which one is a better investment now.
The Case for AEHRAehr, with a market cap of $2.6 billion, enters fiscal 2027 with a significantly broader revenue base than it had two years ago. Nearly 95% of fiscal 2026 revenues came from markets outside silicon carbide for EVs, with AI accelerators, CPUs and network processors accounting for about 71% of annual revenues. Silicon photonics contributed another 20%, giving the company greater exposure to AI infrastructure and data-center demand.
AI-related wafer-level burn-in remains the key growth engine. Aehr’s lead AI processor customer has doubled its FOX system purchases and is forecasting higher wafer allocations, while another major AI processor supplier completed benchmark testing with results that exceeded expectations and is considering pilot production validation. The latter opportunity could generate revenues from both FOX systems and WaferPak contactors if it advances to production. In August 2026, Aehr received a $22 million follow-on production order from its lead AI processor customer for multiple fully automated FOX-XP wafer-level burn-in systems, FOX WaferPak contactors and Auto Aligners.
Silicon photonics is another growth avenue as AI data centers increasingly rely on optical I/O and high-speed interconnects. Aehr’s lead customer continues to place follow-on orders, while a newer networking customer has already ordered two FOX wafer test cells and two FOX-NP systems and provided a forecast for additional systems as it expands capacity for hyperscale data-center deployments.
The company is also expanding into power semiconductors, with more than a dozen GaN WaferPak designs being sampled by potential customers and its first FOX system sold for a silicon MOSFET wafer-level burn-in application. Aehr is simultaneously working to broaden its opportunity in memory, including NAND and HBM-related applications. It is also developing memory-optimized Blades for its FOX-XP and FOX-NP platforms, with potential orders targeted for fiscal 2027 and production ramps potentially extending into fiscal 2028.
The expanding demand is supported by strong order visibility. Aehr ended fiscal 2026 with a record backlog of $80.6 million, which rose to about $100.6 million following subsequent bookings, providing solid visibility into upcoming shipments. In the fourth quarter of fiscal 2026, its net revenues grew 33.3% year over year. The company expects fiscal 2027 revenues of $130 million to $150 million, representing 2.6 to 3 times fiscal 2026 revenues.
AEHR beat earnings estimates in three of the past four quarters and met once, with an average surprise of 321.9%.
The Case for COHUCohu, with a market cap of $2.3 billion, is benefiting from a recovery in core semiconductor markets alongside increasing demand for equipment tied to AI infrastructure. In the second quarter of 2026, its net sales rose 38.4% year over year to $149 million, while computing represented 46% of system orders and increased 150% year over year. Industrial orders also grew 87%, pointing to broader improvement beyond the high-performance computing market.
Its Eclipse thermal handlers are gaining traction with high-performance computing customers, while the company is also expanding its presence with fabless chipmakers and hyperscalers as their programs move from qualification into production. COHU is broadening its growth opportunities beyond HPC through HBM inspection, power semiconductors and advanced connectivity. The company has shipped inspection systems for HBM3, HBM4 and HBM4E and is pursuing opportunities tied to GaN devices and next-generation connectivity.
COHU is also expanding its focus on software analytics, which could increase the recurring revenue contribution to its business. Its PACE analytics platform is gaining adoption among HPC customers, while the company is developing on-site AI capabilities that allow semiconductor manufacturers to analyze equipment and production data within their own facilities.
Cohu is also increasing manufacturing capacity to accommodate the growing HPC pipeline. Production of HPC handlers in Malaysia is being expanded substantially, with additional capacity planned through 2027. At the same time, the company continues investing in R&D and production resources to pursue design wins across AI data centers, HBM and physical AI applications.
Cohu beat earnings estimates in two of the past four quarters and missed twice.
However, in the second quarter of 2026, management reported that rising HPC demand has lengthened lead times and increased input costs for certain semiconductors and specialty components. The company is securing critical parts where possible, but shortages could still affect delivery schedules, profitability or customer pricing. Automotive system orders also fell 24% year over year, showing that recovery remains uneven across end markets.
How Do Estimates Compare for AEHR & COHU?The consensus mark for AEHR’s fiscal 2027 earnings has jumped by 54 cents to 70 cents per share over the past 60 days. The company reported earnings of 3 cents per share in fiscal 2026.
The Zacks Consensus Estimate for COHU’s 2026 earnings is pegged at 97 cents per share, which increased by 37 cents over the past 30 days.
Price Performance ComparisonIn the year-to-date period, AEHR outperformed COHU and the S&P 500.
Valuation: AEHR vs. COHUComing to the valuation story, it seems that investors are willing to pay a premium for Aehr compared to Cohu. This is reflected in AEHR’s forward 12-month price/sales (P/S) of 16.56X compared with COHU’s 3.24X.
Image Source: Zacks Investment Research
Price TargetAehr currently trades below its average analyst price target of $130, implying an attractive 43.7% potential upside from current levels. Meanwhile, Cohu currently trades below its average analyst price target of $70.88, implying a 37.1% potential upside from current levels.
ConclusionBoth Aehr and Cohu are positioned to benefit from rising semiconductor testing demand, particularly from AI infrastructure and advanced devices. Cohu offers a broader product portfolio and is expanding across HPC, HBM inspection, power semiconductors and software analytics, while Aehr is gaining momentum across AI processors, silicon photonics, power semiconductors and memory applications.
However, AEHR appears to have the stronger growth profile at present, supported by rapid business diversification, a record backlog, growing AI-related orders and an ambitious fiscal 2027 revenue outlook. Despite trading at a significantly higher valuation than COHU, its stronger growth visibility and expanding opportunities across multiple high-growth semiconductor markets make AEHR the better buy now. AEHR currently carries a Zacks Rank #2 (Buy), while COHU has a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Algert Global LLC bought a new position in shares of Aehr Test Systems (NASDAQ:AEHR – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 82,275 shares of the semiconductor company’s stock, valued at approximately $7,903,000. Algert Global LLC owned 0.25% of Aehr Test Systems at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Advocate Investing Services LLC acquired a new stake in Aehr Test Systems in the second quarter valued at approximately $26,000. Compagnie Lombard Odier SCmA acquired a new stake in shares of Aehr Test Systems during the 2nd quarter valued at $34,000. KBC Group NV bought a new stake in Aehr Test Systems during the 1st quarter worth $30,000. Sunbelt Securities Inc. bought a new stake in Aehr Test Systems during the 3rd quarter worth $27,000. Finally, Tema ETFs LLC acquired a new position in Aehr Test Systems in the 2nd quarter worth about $89,000. 69.69% of the stock is currently owned by institutional investors and hedge funds.
Aehr Test Systems Stock Performance AEHR stock opened at $91.12 on Thursday. The stock’s 50 day simple moving average is $93.62 and its 200 day simple moving average is $76.40. The company has a market cap of $2.97 billion, a P/E ratio of -379.65 and a beta of 3.10. Aehr Test Systems has a fifty-two week low of $18.70 and a fifty-two week high of $147.40.
Analyst Ratings Changes AEHR has been the topic of several research reports. Craig Hallum restated a “buy” rating and set a $125.00 price target on shares of Aehr Test Systems in a report on Wednesday, July 15th. Wall Street Zen raised shares of Aehr Test Systems from a “sell” rating to a “hold” rating in a research note on Saturday, July 18th. Jefferies Financial Group initiated coverage on shares of Aehr Test Systems in a report on Thursday, August 13th. They set a “buy” rating and a $175.00 price target on the stock. Freedom Capital upgraded Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 16th. Finally, Zacks Research upgraded Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 17th. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $136.67. Get Our Latest Stock Report on Aehr Test Systems
Insider Transactions at Aehr Test Systems In other Aehr Test Systems news, COO Adil Engineer sold 15,000 shares of the business’s stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $131.02, for a total value of $1,965,300.00. Following the sale, the chief operating officer directly owned 46,977 shares in the company, valued at $6,154,926.54. The trade was a 24.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Gayn Erickson sold 40,000 shares of the business’s stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $130.84, for a total value of $5,233,600.00. Following the completion of the sale, the chief executive officer owned 157,723 shares in the company, valued at $20,636,477.32. This represents a 20.23% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 109,475 shares of company stock worth $13,827,160. 6.80% of the stock is owned by insiders.
(Free Report)
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Featured Stories Five stocks we like better than Aehr Test Systems Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise Alcoa’s Gallium Project Opens a New Door Beyond Aluminum Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech Can Tesla’s Flying Roadster Distract From Its Real Risks? Want to see what other hedge funds are holding AEHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aehr Test Systems (NASDAQ:AEHR – Free Report).
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
FREMONT, CA / ACCESS Newswire / August 21, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced that it will participate in the Jefferies semiconductor, IT Hardware & Communications Technology Conference taking place August 24-25, 2026, at the Four Seasons Hotel in Chicago. President and CEO Gayn Erickson and CFO Chris Siu will be hosting meetings with investors throughout the day on Tuesday, August 25.
"We look forward to discussing with investors and shareholders Aehr's expanding role in enabling the next generation of semiconductor devices across a wide range of markets," said Mr. Erickson. "Aehr delivers complete turnkey solutions that improve the quality, reliability, and yield of semiconductors used in critical applications, including AI processors in cloud computing and data centers, silicon carbide devices in electric vehicles and charging infrastructure, gallium nitride for advanced power conversion, and silicon photonics for data centers, 5G infrastructure and optical input/output (I/O). We are seeing strong traction with AI processors in both wafer-level and package-level formats. The growing adoption of wafer-level and package-level test and burn-in across these markets is expected to be a significant growth driver for Aehr Test Systems."
For additional information or to schedule a meeting with Aehr management, please contact your Jefferies representative or Aehr's investor relations firm, PondelWilkinson, Inc., at [email protected].
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer-level, singulated die, and package-level form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, advanced artificial intelligence (AI) processors, data and telecommunications infrastructure, and solid-state memory and storage, are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr's products and solutions. Aehr has developed and introduced several innovative products including the FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full-wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full-wafer contactor capable of testing wafers up to 300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. Acquired through its acquisition of Incal Technology, Inc., Aehr's new line of high-power package-level reliability/burn-in test solutions for AI semiconductor manufacturers, including its ultra-high-power Sonoma family of test solutions for AI accelerators, GPUs, and high-performance computing (HPC) processors, position Aehr within the rapidly growing AI market as a turnkey provider of reliability and testing that span from engineering to high volume production. For more information, please visit Aehr Test Systems' website at www.aehr.com.
Key Takeaways Its newest major customer has ordered two FOX test cells and two FOX-NP systems.AEHR's lead silicon photonics customer is ramping production and placing follow-on wafer-level burn-in orders.AEHR projects $130-$150 million in fiscal 2027 revenue, with non-GAAP net income at 18%-22%. Aehr Test Systems, Inc. (AEHR - Free Report) is gaining momentum in silicon photonics, giving it another potential growth driver alongside AI processors. Demand for production burn-in is increasing as AI data centers rely more on optical I/O and high-speed interconnects. The company believes the silicon photonics and optical test and burn-in market could become a meaningful long-term growth driver.
Aehr’s lead silicon photonics customer is ramping up production and has placed follow-on orders for fully automated wafer-level burn-in systems. Its newest major customer, a global networking products provider, expects additional systems as it expands capacity to support next-generation hyperscale data center deployments. The customer first engaged with AEHR last November and has already ordered two FOX test cells and two FOX-NP systems.
The financial opportunity is becoming more visible. Management currently expects silicon photonics to account for roughly 15-20% of fiscal 2027 revenues, while total revenues are projected to be in the band of $130-$150 million. The outlook is largely based on current customers, and AEHR is not assuming any memory revenue in this guidance. Non-GAAP net income is also expected to reach 18-22% of total revenues in fiscal 2027.
Continued production ramp ups and additional system orders will be important to watch. The company’s growing presence across existing and new customers could help expand the contribution of this market to fiscal 2027 revenues. With silicon photonics already expected to account for 15-20% of fiscal 2027 revenues, further customer ramp ups could make it an increasingly important part of AEHR’s growth.
AEHR’s Key CompetitorsAehr operates in a highly competitive semiconductor test equipment market, competing with established players like FormFactor, Inc. (FORM - Free Report) and Teradyne, Inc. (TER - Free Report) .
FormFactor is seeing demand for its semiconductor test solutions from AI, advanced packaging and silicon photonics. FORM is positioned to benefit as chipmakers increase testing requirements for increasingly complex semiconductor devices.
Teradyne is benefiting from semiconductor testing demand linked to AI and advanced computing. TER also has a broad customer base across the semiconductor industry, giving it exposure to continued investments in data centers and next-generation computing.
AEHR’s Share Price Performance, Valuation & EstimatesAEHR’s shares have surged 59.3% over the past month, outperforming the broader industry’s 17.9% growth.
Image Source: Zacks Investment Research
Aehr’s shares are trading at a premium. In terms of the forward 12-month price-to-sales (P/S), AEHR is trading at 25.65X, higher than the industry’s 6.67X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for AEHR’s fiscal 2027 earnings is pinned at 70 cents per share, implying a sharp increase from 3 cents a year ago.
Shares of semiconductor test equipment names are sliding Wednesday morning as a broad derisking wave hits some of 2026’s biggest chip winners. Aehr Test Systems (NASDAQ:AEHR) stock is down 10% to $111.01, leading the group lower after one of the largest year-to-date runs anywhere in the sector.
Teradyne (NASDAQ:TER | TER Price Prediction) stock is down 5% to $383.80. FormFactor (NASDAQ:FORM) shares are down 6% to $117.27. Cohu (NASDAQ:COHU) stock is down 6% to $55.73. The SPDR S&P Semiconductor ETF (NYSEARCA:XSD) is down 2% to $508.08, a much smaller decline that shows how concentrated the selling is in the test names.
No company-specific catalyst has been reported for any of the four test-equipment stocks today. The move reads as sector-wide profit-taking after enormous year-to-date gains, and the pullback comes despite relief in the bond market. The Treasury Department said it would increase buybacks of long-dated government debt “by at least double” for securities in the 10-year to 30-year sector, and the 30-year yield declined 8 basis points to 5.2% after hitting its highest level since 2007 earlier this week.
Aehr Test Systems Leads the Test-Name Selloff Aehr Test Systems stock had entered Wednesday up 510% year to date through Tuesday’s close, easily the largest run in this peer group. That vertical move sets up an outsized reaction on any AI-hardware derisking day, and today the shares are giving back a chunk of that gain.
The company designs wafer-level burn-in and test systems, including the FOX-P family, along with ultra-high-power packaged part burn-in systems in the Sonoma family, serving AI accelerators, GPUs, high-performance computing processors, and silicon carbide power semiconductors. Aehr Test Systems reported trailing twelve-month revenue of $50.9 million and a trailing twelve-month net loss of $7.1 million, with fiscal fourth quarter revenue of $18.8 million for the quarter ended May 29, up from $14.1 million a year earlier.
Separately, Aehr Test Systems disclosed in a Form 4 filing with the SEC that President and Chief Executive Officer Gayn Erickson sold 40,000 shares of common stock on August 12, valued at $5.2 million, at a weighted average price of $130.84. The sale was executed entirely through indirect holdings held by a trust, reducing that specific interest by 20%. Erickson retains 197,521 directly held shares and 157,723 indirectly held shares, and executive sales conducted through trusts are routine and commonly reflect diversification or pre-set plans.
Peer Test-Equipment Names Follow the Move Teradyne stock is the second-largest name in this group by year-to-date performance, up 109% year to date through Tuesday’s close before Wednesday’s 5% decline. Teradyne supplies automatic test equipment used in the production of AI accelerators, memory, and networking silicon, and is one of the most direct large-cap plays on rising test intensity per die.
Meanwhile, FormFactor shares are down 6% after a 123% year-to-date run through Tuesday’s close. FormFactor makes advanced probe cards used in wafer testing for high-bandwidth memory and logic devices, a niche tightly correlated with AI accelerator and memory build-outs.
Additionally, Cohu stock is falling 6% after a 139% year-to-date gain. Cohu supplies test handlers and contactors for high-performance computing and data-center processors, giving it the same AI-hardware exposure that is now being trimmed across the group.
SPDR S&P Semiconductor ETF Softens Less The SPDR S&P Semiconductor ETF is down 2% to $508.08, well shy of the drawdowns in the individual test names. The fund is up 61% year to date through Tuesday’s close and offers broad semiconductor exposure rather than a targeted test-equipment vehicle.
Top XSD holdings include Marvell Technology, Power Integrations, Cirrus Logic, On Semiconductor, and Impinj, meaning the ETF blends analog, connectivity, memory, and logic names alongside a smaller slice of test exposure. That broader mix explains why its decline is a fraction of what Aehr Test Systems, Teradyne, FormFactor, and Cohu are printing today.
The sector concentration is still worth flagging. The XSD fund sits inside a single industry, so drawdowns can compound if the broader chip complex rolls over rather than staying isolated in the test cohort.
What to Watch The setup points to positioning and profit-taking in AI hardware winners rather than a rates problem, given long-end yields eased on the day. Traders can watch for signs of support in the test names into the close, or further downside as momentum unwinds.
Shareholders may want to keep an eye on whether the SPDR S&P Semiconductor ETF joins the selling in earnest or holds firm, which can help clarify whether this is a targeted rotation out of test equipment or the front edge of a broader chip pullback.
Contact [email protected] for any questions or corrections.
On August 17, 2026, Aehr Test Systems
AEHR +8.62% 64
shares rose 8.6% to a current price of $145.82, reflecting a significant increase in price as it trades near its 52-week high of $147.40, compared to a low of $16.38. The stock has experienced remarkable performance, with a year-to-date increase of 622.2% and an impressive 696.4% gain over the past year.
GF Value™ verdict: $13.53 indicates the stock is 977.8% overvalued.GF Score™ of 64/100 suggests an above-average potential based on various financial metrics.Notable signal: Insiders have sold $61.9M of stock over the past 12 months with no reported buying.Is AEHR Overvalued or Undervalued?Aehr Test Systems
AEHR +8.62% 64
currently trades at $145.82, while the GF Value™ estimate stands at $13.53. This substantial difference indicates that AEHR is considerably overvalued, with a staggering margin of 977.8% over the GF Value™ estimate. The GF Value™ is a proprietary calculation by GuruFocus that considers historical trading multiples, past business growth, and projected future performance to determine a stock's intrinsic value. Given that AEHR is unprofitable and cash-flow negative, relying on earnings-based valuations, such as Price-to-Earnings (P/E) ratios, may not be applicable. Instead, a Price-to-Sales (P/S) analysis would provide a more relevant valuation context. The stock's current P/S is significantly higher than its historical median of approximately 4.7x, which raises concerns about its current valuation level.
The GF Valuation label classifies AEHR as significantly overvalued, which adds a layer of risk for potential investors. The considerable gap between the market price and the projected intrinsic value suggests that investors may be paying a premium that does not correspond with the company's underlying financial fundamentals.
How Does AEHR's Valuation Compare to Its History?MetricCurrentHistoricalP/E (TTM)228.2x39.7xAehr Test Systems' current forward P/E of 228.2x is dramatically above its 5-year median P/E of 39.7x, indicating that the stock is trading at a level significantly higher than its historical valuation. This analysis aligns with the GF Value™ verdict, reinforcing the conclusion that AEHR is overvalued based on historical earnings multiples.
What Does AEHR's GF Score™ Tell Us?The GF Score™ is a comprehensive measurement that evaluates a stock's value based on financial strength, profitability, growth potential, valuation, and momentum. Aehr Test Systems has a GF Score™ of 64/100, indicating above-average potential. The strongest sub-rank is in growth, with a score of 7/10, suggesting that the company may have solid future growth prospects. Conversely, the weakest area lies in valuation, where it scores only 1/10, highlighting significant concerns regarding its current price relative to its intrinsic worth.
MetricRatingGF Score™64/100Financial Strength7/10Profitability4/10Growth7/10Valuation1/10Momentum6/10Together, these scores suggest that while Aehr Test Systems has strong growth potential and adequate financial strength, the extreme valuation rank indicates that current market prices may not be justified. The valuation concerns raise questions about the sustainability of the stock's high price in light of its financial performance.
What Are Gurus and Insiders Doing with AEHR?Currently, six gurus hold positions in Aehr Test Systems, with three increasing their holdings and four reducing them in recent quarters. This mixed signal indicates a lack of consensus among institutional investors regarding the stock's future potential. Additionally, insider activity reflects a concerning trend, as insiders have sold a total of $61.9 million worth of stock over the past 12 months without any buying, suggesting a lack of confidence in the stock's future performance from those closest to the company.
The trend of insiders selling their shares can be interpreted as a warning sign, as it may indicate that those with the most knowledge about the company's operations do not view the current price as sustainable or justified. This insider selling, coupled with the mixed guru activity, adds to the cautionary outlook regarding AEHR's current valuation.
What This Means for InvestorsIn conclusion, Aehr Test Systems appears significantly overvalued based on the GF Value™ estimate, which suggests that the current price of $145.82 is not supported by the company's underlying financial situation. The high P/S ratio relative to its historical median further underscores the risk of overvaluation. Given the mixed signals from guru activity and the concerning trend in insider selling, potential investors should approach with caution. For more detailed insights, visit the Aehr Test Systems
AEHR +8.62% 64
stock page.
Frequently Asked QuestionsWhat is AEHR's GF Score™?
AEHR has a GF Score™ of 64/100, indicating its above-average potential based on various financial metrics.
Is AEHR overvalued or undervalued?
AEHR is currently overvalued, with a GF Value™ estimate of $13.53, suggesting a significant discrepancy between market price and intrinsic value.
What is AEHR's P/E ratio?
AEHR's forward P/E is 228.2x, which is substantially higher than its 5-year median P/E of 39.7x, indicating a significant overvaluation compared to its historical averages.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Key Takeaways Softer inflation and jobs data boosted hopes for a Fed rate-hike pause. NVIDIA's $500B AI push could create fresh opportunities across financials. Leveraged ETFs magnified gains in Nebius, SanDisk, Aehr and Unusual Machines. Wall Street delivered a mixed performance last week. The S&P 500 added about 0.5%, the Dow Jones Industrial Average lost about 0.6%, and the Nasdaq-100 surged about 1.1% as growth stocks rallied on hopes that the Fed will keep interest rates unchanged at its September meeting, easing earlier concerns about a potential rate hike.
Cooling Inflation Cools Fed Rate-Hike BetsExpectations for another Federal Reserve rate hike have cooled following the latest inflation data. The annual inflation rate in the United States slowed for a second successive month to 3.4% in July 2026, from 3.5% in June, in line with expectations.
The impact of the energy shock caused by the war with Iran continued to ease. On a monthly basis, the CPI rose 0.1% as expected, rebounding from a 0.4% decline in June.
Core CPI, which excludes volatile food and energy prices, rose 0.2% sequentially (following a flat reading in June) and 2.5% year over year, down from 2.6% in June, per Trading Economics (read: 5 ETFs to Benefit From Cooling Inflation in the Near Term).
The chances of the Fed keeping interest rates unchanged at its September meeting have now risen to 66.9%, up from 51.5% a month ago, per CME FedWatchTool (at the time of writing).
The benign inflation report came shortly after July's disappointing jobs data, which showed an unexpected loss of 23,000 nonfarm jobs. The combination of softer inflation and a weakening labor market has reduced the urgency for the Fed to raise interest rates at its September meeting.
NVIDIA's $500B AI PushNVIDIA (NVDA - Free Report) announced last week that it had entered into memorandums of understanding with Apollo Global Management (APO), BlackRock (BLK), Blackstone (BX), Brookfield (BAM), Goldman Sachs (GS) and KKR (KKR) to establish financing platforms aimed at supporting its customers, as quoted on CNBC (read: Does NVIDIA's $500B AI Push Open a New Opportunity for Financial ETFs?).
Winning Leveraged ETFs in Focus Against this backdrop, below we highlight a few winning leveraged ETFs of last week.
Graniteshares 2X Long NBIS Daily ETF (NBIL - Free Report) – Up 107.3%
Nebius Group (NBIS - Free Report) – an AI-centric cloud platform built for intensive AI workloads – saw its shares surge about 50% last week.
Leverage Shares 2X Long SNDK Daily ETF (SNDG - Free Report) – Up 80.3%
SanDisk (SNDK - Free Report) ’ shares – developer and seller of data storage devices and solutions based on NAND flash technology – added 36.3% last week.
Leverage Shares 2X Long AEHR Daily ETF (AEHG - Free Report) – Up 56.9%
Aehr Test Systems (AEHR - Free Report) – developer of systems which are designed to reduce the cost of testing DRAMs and other memory devices – saw its shares surge 27.7% last week.
Defiance Daily Target 2X Long UMAC ETF (UMAL - Free Report) – Up 48.6%
Shares of Unusual Machines (UMAC - Free Report) a manufacturer of U.S.-made, NDAA-compliant drone components and small unmanned aircraft systems, added about 28.1% last week.
Belpointe Asset Management LLC decreased its holdings in shares of Aehr Test Systems (NASDAQ:AEHR – Free Report) by 64.8% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,289 shares of the semiconductor company’s stock after selling 7,892 shares during the quarter. Belpointe Asset Management LLC’s holdings in Aehr Test Systems were worth $412,000 as of its most recent SEC filing.
A number of other hedge funds have also modified their holdings of AEHR. Royal Bank of Canada grew its position in shares of Aehr Test Systems by 262.7% in the first quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock valued at $365,000 after purchasing an additional 36,364 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Aehr Test Systems by 8.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock worth $126,000 after purchasing an additional 1,344 shares during the period. JPMorgan Chase & Co. raised its stake in Aehr Test Systems by 7.9% during the second quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock worth $201,000 after purchasing an additional 1,145 shares during the period. Legal & General Group Plc boosted its holdings in Aehr Test Systems by 110.8% in the 2nd quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock valued at $89,000 after purchasing an additional 3,617 shares during the last quarter. Finally, Rhumbline Advisers boosted its holdings in Aehr Test Systems by 3.1% in the 2nd quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock valued at $536,000 after purchasing an additional 1,254 shares during the last quarter. 69.69% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth A number of research firms recently commented on AEHR. Wall Street Zen upgraded Aehr Test Systems from a “sell” rating to a “hold” rating in a report on Saturday, July 18th. Jefferies Financial Group initiated coverage on Aehr Test Systems in a research note on Thursday. They set a “buy” rating and a $175.00 target price for the company. Lake Street Capital restated a “buy” rating and issued a $110.00 target price on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Craig Hallum reaffirmed a “buy” rating and issued a $125.00 price target on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Finally, Zacks Research upgraded Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Friday, July 17th. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $136.67.
Read Our Latest Report on Aehr Test Systems
Insider Activity In other news, CEO Gayn Erickson sold 40,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $130.84, for a total value of $5,233,600.00. Following the completion of the sale, the chief executive officer directly owned 157,723 shares of the company’s stock, valued at $20,636,477.32. This trade represents a 20.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Rhea J. Posedel sold 8,413 shares of the stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $130.00, for a total value of $1,093,690.00. Following the completion of the transaction, the director owned 387,962 shares of the company’s stock, valued at $50,435,060. The trade was a 2.12% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 109,475 shares of company stock valued at $13,827,160 over the last ninety days. 6.80% of the stock is currently owned by company insiders.
Key Aehr Test Systems News Here are the key news stories impacting Aehr Test Systems this week:
Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation Aehr Test Systems Stock Up 8.7% AEHR opened at $134.06 on Friday. Aehr Test Systems has a 52 week low of $16.38 and a 52 week high of $147.40. The business has a 50 day moving average price of $92.83 and a two-hundred day moving average price of $71.45. The company has a market cap of $4.37 billion, a PE ratio of -558.56 and a beta of 3.10.
Aehr Test Systems Profile (Free Report)
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Read More Five stocks we like better than Aehr Test Systems Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors Quantum Leaps: Debt-Free as AI Storage Demand Accelerates NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270 Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEBIP Wealth LLC Buys Shares of 24,481 Sterling Infrastructure, Inc. $STRL
NEXT HEADLINE »BIP Wealth LLC Takes Position in American Express Company $AXP
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Shares of Aehr Test Systems (NASDAQ:AEHR) are up roughly 8% in Friday midday, after a fresh Wall Street initiation lit another fire under one of 2026’s most explosive small caps. The move extends a year-to-date advance of 510.7% and pushes the stock through its 52-week high of $133.35.
Jefferies Buy Rating and $175 Target Fuel the Move Jefferies initiated coverage of Aehr today with a Buy rating and a $175 price target, and importantly, the firm called its own model conservative. “We see credible upside to our estimates, built only on programs already in production and backlog booked. Our model excludes memory, CPO, conversion of the AI benchmark customer, and a return to peak SiC,” Jefferies wrote. In plain English, the target does not require a silicon carbide recovery, a memory win, or the huge AI benchmark customer converting to production. Those are all free options.
The analyst also laid out the structural case: “We see AI/AP/SiPho as a significant LT catalyst, as rising chip value, higher power envelopes, chiplet/HBM integration, and compounding package-yield risk all increase reliability-test intensity.” Translation for a non-specialist reader. AI accelerators run hotter, cost more, and stack more dies into a single package. That makes it far more expensive to discover a bad chip late, so buyers want to screen at the wafer level before packaging. That’s exactly what Aehr’s FOX family of wafer-level burn-in systems and its Sonoma ultra-high-power packaged-part burn-in platform do.
Jefferies also flagged the mix shift as the real story: “AEHR has undergone one of the semi equipment sector’s most significant mix transformations, with SiC more than 90% of FY24 revenue and now AI over 90% of FY26 revenue. Additionally, the top customer has fallen from 79% of revenue in FY23 to an estimated over 25% in FY27E.” Customer concentration risk, long a bear pillar, is fading.
Test Equipment Peers Have Re-Rated, Too Aehr is the standout, but the entire semiconductor test and inspection group has been one of 2026’s strongest pockets of the market. Teradyne (NASDAQ:TER | TER Price Prediction) is up 112% year to date and 261% over one year. Cohu (NASDAQ:COHU) has gained 151% YTD, FormFactor (NASDAQ:FORM) is up 136% YTD, and Onto Innovation (NYSE:ONTO) has advanced 114% YTD. Axcelis Technologies is the laggard of the group at 78% YTD.
The read-through is straightforward. AI chips are harder and more expensive to test than what came before, and every name that touches burn-in, probe, handlers, or wafer inspection is capturing that spend. Aehr’s gain still dwarfs the group, which cuts both ways: more upside already booked into the tape, but far more valuation risk if AI test intensity underdelivers.
Watch the Risk Behind the Rally This is still a small cap with a market value around $4.35 billion, lumpy order-driven revenue (Q3 FY26 revenue was $10.31 million, down 43.7% YoY), and a beta of 3.09. Insiders have been steady sellers into the rally, including the CEO and CFO through July, per Form 4 filings. A stock up more than 500% year to date carries extreme valuation risk on any AI test-demand hiccup.
Keep an eye on the stock into the close to see if AEHR can hold this breakout above its prior 52-week high. The next catalyst is management’s fiscal 2027 order flow commentary, where the CEO has already guided to revenue of $130 million to $150 million.
Contact [email protected] for any questions or corrections.
Gayn Erickson, President and Chief Executive Officer of Aehr Test Systems, Inc. (AEHR +6.82%), sold 40,000 shares of common stock on August 12, 2026, as disclosed in a recent SEC Form 4 filing.
Transaction summaryMetricValueTransaction value$5.2 millionShares sold (indirectly held)40,000Post-transaction shares (directly held)197,521Post-transaction shares (indirectly held)157,723Post-transaction value$45.91 millionTransaction value based on SEC Form 4 weighted average sale price ($130.84); post-transaction value based on August 12, 2026 market close ($129.23).
Key questionsWhat was the structural nature of this transaction?
The sale was executed entirely through indirect holdings held by a trust, resulting in a 20% reduction of that specific interest while Gayn Erickson maintained his direct ownership of 197,521 shares.How does the execution price compare to current market levels?
The shares were sold at a weighted average price of $130.84, which was higher than the $129.23 market close on the transaction date of August 12, 2026.What remains of the insider's total equity exposure?
Following this transaction, Erickson retains a total beneficial interest of ~355,000 shares, a figure that includes unvested restricted stock units (RSUs) and unvested restricted shares.What is the financial context surrounding this disposal?
This sale occurred while the company reported trailing twelve-month revenue of $50.9 million and a net loss of $7.1 million as of the latest reporting interval.Company OverviewMetricValueShare Price (as of market close 2026-08-12)$129.23Market Capitalization$4.2 billionRevenue (TTM)$50.9 millionNet Income (TTM)-$7.1 millionCompany SnapshotAehr Test Systems designs and manufactures advanced burn-in and test systems for integrated circuits, including logic, optical, and memory devices, with a comprehensive product portfolio featuring the ABTS and FOX-P families of solutions.The company generates revenue through the sale of specialized test and burn-in equipment, complementary components such as WaferPak aligners and contactors, and related services to semiconductor manufacturers and device producers globally.The company primarily serves semiconductor manufacturers, integrated device manufacturers, and contract manufacturers requiring advanced testing and burn-in capabilities for quality assurance and device reliability validation.Aehr Test Systems is a specialized semiconductor equipment manufacturer leveraging nearly five decades of engineering expertise since its 1977 founding. The company maintains a focused operational footprint with 138 employees in Fremont, California, while serving a global customer base requiring mission-critical test and burn-in solutions.
Despite current profitability challenges reflected in trailing 12-month net losses, the company's significant stock appreciation of 564.42% over the past year reflects investor confidence in its market positioning within the high-growth semiconductor testing equipment sector.
What this transaction means for investorsAehr Test Systems CEO Gayn Erickson's Aug. 12 sale of company stock for a weighted average price of $130.84 came at a time when shares were soaring. The stock hit a 52-week high of $147.40 on Aug. 14, just days after his disposition.
Erickson had been steadily disposing of shares as the stock price rose in 2026. This is his latest sale, and represents a sizable 20% of the insider's indirect holdings and 10% of total equity holdings in the company. It appears he was capitalizing on the share price appreciation to lock in gains.
Erickson retains approximately 355,000 total shares in the company post-transaction, and because these holdings include unvested RSUs and other restricted shares, the size of further sales is limited until these vest, ensuring continued alignment with shareholder interests.
Aehr Test Systems stock has been on an amazing run because its business has benefited from the rise of artificial intelligence. The earnings report for its fiscal fourth quarter, ended May 29, saw revenue grow to $18.8 million, up from $14.1 million in the prior year.
Robert Izquierdo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
California State Teachers Retirement System grew its stake in Aehr Test Systems (NASDAQ: AEHR) by 2,271.7% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 41,599 shares of the semiconductor company's stock after acquiring an additional 39,845 shares during the period. California State Teachers Retirement
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
BMO Capital analyst Max Yerrill initiated coverage on Energy Fuels Inc (AMEX:UUUU) with an Outperform rating and announced a price target of $18. Energy Fuels closed at $14.58 on Thursday. See how other analysts view this stock. Raymond James analyst Christopher Raymond initiated coverage on SpyGlass Pharma Inc (NASDAQ:SGP) with an Outperform rating and announced a price target of $39. SpyGlass Pharma shares closed at $25.17 on Thursday. See how other analysts view this stock. Seaport Global analyst Jay Goldberg initiated coverage on ADI Global Distribution Inc (NYSE:ADIG) with a Buy rating and announced a price target of $35. ADI Global Distribution closed at $25.82 on Thursday. See how other analysts view this stock. Jefferies analyst Kevin Garrigan initiated coverage on Aehr Test Systems, Inc. (NASDAQ: AEHR) with a Buy rating and announced a price target of $175. Aehr Test System shares closed at $123.30 on Thursday. See how other analysts view this stock. Considering buying SGP stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Key Takeaways Aehr won a $22M follow-on order for WLBI systems from its lead AI processor customer.The FOX-XP can test and burn in nine 300mm wafers at once, screening reliability before packaging.Aehr reported a $100.6M backlog and $60.7M record quarterly bookings at fiscal 2026's end. Aehr Test Systems, Inc. (AEHR - Free Report) has secured a $22 million follow-on production order from its lead AI processor customer, signaling growing adoption of wafer-level burn-in (WLBI) as AI chips become more complex and costly. The systems are expected to ship over the next six months to the customer’s high-volume manufacturing partner in Taiwan, supporting production of advanced AI training and inference processors.
The order includes multiple FOX-XP systems, FOX WaferPak contactors and Auto Aligners. Each FOX-XP can simultaneously test and burn in nine 300mm wafers, enabling manufacturers to identify early-life reliability issues before chips are packaged. This can help reduce the risk of committing expensive HBM, substrates and interposers to dies that may later fail reliability screening, making WLBI increasingly relevant as AI package complexity rises.
The latest win builds on AEHR’s momentum. In February, the company received a $14 million order from the same lead AI processor customer. It reported a $100.6 million effective backlog at the end of fiscal 2026, while fiscal 2027 revenue guidance of $130-$150 million points to substantial year-over-year growth. Record quarterly bookings of $60.7 million at the fiscal fourth-quarter end also indicate strong demand for its test and burn-in solutions across multiple applications.
Additionally, the company is engaging with additional semiconductor companies and hyperscalers following positive WLBI benchmark results, while targeting applications spanning AI accelerators, CPUs, network processors, memory and HBM. As chip values, power requirements and advanced packaging complexity increase, broader adoption of WLBI could create a meaningful growth avenue for Aehr.
AEHR Faces Stiff CompetitionAehr operates in a highly competitive semiconductor test equipment market, contending with strong rivals such as Teradyne, Inc. (TER - Free Report) and FormFactor, Inc. (FORM - Free Report) .
Teradyne is benefiting from robust AI-related semiconductor testing demand, with its semiconductor test business gaining from higher testing requirements for advanced chips. Strong orders from AI and high-performance computing applications position TER well as chip complexity and testing intensity continue to rise.
FormFactor is benefiting from rising AI and HBM test requirements, with demand for advanced probe cards supported by increasingly complex processors and packaging. FORM’s wafer-level testing capabilities position the company well as semiconductor manufacturers increase testing intensity to improve yield and reliability.
AEHR’s Share Price Performance, Valuation & EstimatesAEHR’s shares have surged 79.5% over the past month, outperforming the broader industry’s 7.9% growth.
Image Source: Zacks Investment Research
Aehr shares are trading at a premium. In terms of the forward 12-month price-to-sales (P/S), AEHR is trading at 27.11X, higher than the industry’s 6.31X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for AEHR’s fiscal 2027 earnings is projected at 70 cents per share, a sharp increase from 3 cents a year ago.
Image Source: Zacks Investment Research
Aehr currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Qnity Electronics (NYSE:Q – Get Free Report) and Aehr Test Systems (NASDAQ:AEHR – Get Free Report) are both technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.
Institutional and Insider Ownership 69.7% of Aehr Test Systems shares are held by institutional investors. 0.2% of Qnity Electronics shares are held by insiders. Comparatively, 6.8% of Aehr Test Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Profitability This table compares Qnity Electronics and Aehr Test Systems’ net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Qnity Electronics 11.25% 10.83% 6.26% Aehr Test Systems -14.25% -3.83% -3.36% Analyst Recommendations This is a summary of recent recommendations for Qnity Electronics and Aehr Test Systems, as provided by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qnity Electronics 0 1 8 1 3.00 Aehr Test Systems 1 0 3 2 3.00 Qnity Electronics currently has a consensus target price of $151.78, suggesting a potential upside of 6.77%. Aehr Test Systems has a consensus target price of $117.50, suggesting a potential downside of 9.08%. Given Qnity Electronics’ higher probable upside, equities research analysts clearly believe Qnity Electronics is more favorable than Aehr Test Systems.
Valuation & Earnings This table compares Qnity Electronics and Aehr Test Systems”s top-line revenue, earnings per share and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Qnity Electronics $4.75 billion 6.26 $692.00 million $2.80 50.77 Aehr Test Systems $50.00 million 84.31 -$7.13 million ($0.24) -538.46 Qnity Electronics has higher revenue and earnings than Aehr Test Systems. Aehr Test Systems is trading at a lower price-to-earnings ratio than Qnity Electronics, indicating that it is currently the more affordable of the two stocks.
Summary Qnity Electronics beats Aehr Test Systems on 9 of the 13 factors compared between the two stocks.
About Qnity Electronics (Get Free Report)
Qnity Electronics Inc. is a premier technology solution provider across the semiconductor value chain. Qnity Electronics Inc. is based in WILMINGTON, Del.
About Aehr Test Systems (Get Free Report)
Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The company also offers FOX-CP system, a low-cost single-wafer compact test solution for logic, memory, and photonic devices; FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, it provides FOX DiePak Carrier, a reusable temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules; and FOX DiePak Loader. The company was incorporated in 1977 and is headquartered in Fremont, California.
Receive News & Ratings for Qnity Electronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qnity Electronics and related companies with MarketBeat.com's FREE daily email newsletter.
FREMONT, CA / ACCESS Newswire / August 13, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced that it will participate in the 7th Annual Needham Virtual Semiconductor and SemiCap 1x1 Conference on Wednesday, August 19, 2026. Aehr Test President and CEO Gayn Erickson and CFO Chris Siu will be hosting virtual meetings with investors throughout the day.
"We look forward to discussing with investors and shareholders Aehr's expanding role in enabling the next generation of semiconductor devices across a wide range of markets," said Mr. Erickson. "Aehr delivers complete turnkey solutions that improve the quality, reliability, and yield of semiconductors used in critical applications, including AI processors in cloud computing and data centers, silicon photonics for data centers, 5G infrastructure and optical input/output (I/O), silicon carbide devices in electric vehicles and charging infrastructure, and gallium nitride for advanced power conversion. We are seeing strong traction with AI processors in both wafer-level and package-level formats. The growing adoption of wafer-level and package-level test and burn-in across these markets is expected to be a significant growth driver for Aehr Test Systems."
For additional information, or to schedule a meeting with Aehr management, please contact your Needham representative, or Aehr's investor relations firm, PondelWilkinson, Inc., at [email protected].
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer-level, singulated die, and package-level form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including advanced artificial intelligence (AI) processors, silicon photonics, data and telecommunications infrastructure, electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, and solid-state memory and storage are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr's products and solutions. Aehr has developed and introduced several innovative products including the FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full-wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full-wafer contactor capable of testing wafers up to 300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. Acquired through its acquisition of Incal Technology, Inc., Aehr's new line of high-power package-level reliability/burn-in test solutions for AI semiconductor manufacturers, including its ultra-high-power Sonoma family of test solutions for AI accelerators, GPUs, and high-performance computing (HPC) processors, position Aehr within the rapidly growing AI market as a turnkey provider of reliability and testing that span from engineering to high volume production. For more information, please visit Aehr Test Systems' website at www.aehr.com.
Contacts:
Aehr Test Systems
Chris Siu
Chief Financial Officer [email protected]
Dimensional Fund Advisors LP trimmed its holdings in Aehr Test Systems (NASDAQ:AEHR – Free Report) by 14.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 93,037 shares of the semiconductor company’s stock after selling 16,030 shares during the period. Dimensional Fund Advisors LP owned about 0.30% of Aehr Test Systems worth $3,445,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Aehr Test Systems in the fourth quarter worth approximately $25,000. Sunbelt Securities Inc. purchased a new position in shares of Aehr Test Systems during the third quarter valued at approximately $27,000. State of Wyoming purchased a new position in shares of Aehr Test Systems during the second quarter valued at approximately $28,000. KBC Group NV purchased a new position in shares of Aehr Test Systems during the first quarter valued at approximately $30,000. Finally, Russell Investments Group Ltd. grew its holdings in Aehr Test Systems by 3,500.0% during the third quarter. Russell Investments Group Ltd. now owns 2,448 shares of the semiconductor company’s stock worth $74,000 after buying an additional 2,380 shares in the last quarter. 69.69% of the stock is owned by institutional investors.
Aehr Test Systems News Summary Here are the key news stories impacting Aehr Test Systems this week:
Positive Sentiment: Aehr received a $22 million follow-on production order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The order expands the customer’s production capacity and reinforces Aehr’s exposure to artificial intelligence and high-performance computing demand. Aehr receives $22 million follow-on order Positive Sentiment: The company’s recent operating update showed record quarterly bookings of $60.7 million, an effective backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. The order visibility has strengthened expectations for substantial future growth. Aehr Test Systems stock outlook Positive Sentiment: Investors are also focusing on Aehr’s growing role in AI infrastructure, including wafer-level testing for silicon photonics, optical interconnects and next-generation chip-to-chip connectivity. These markets could provide additional long-term growth opportunities. Aehr silicon photonics order and backlog Neutral Sentiment: Reported short interest was zero shares, implying little conventional short-covering pressure. However, the figure may be incomplete or anomalous and offers limited investment insight. Negative Sentiment: Valuation has become demanding after the stock’s sharp advance, leaving AEHR vulnerable to profit-taking or disappointment if orders and growth targets are not achieved. Aehr Test Systems valuation risks Negative Sentiment: Vice President Alistair Sporck sold 1,000 shares for about $108,490, reducing his holdings by roughly 4.25%. The transaction adds to a broader pattern of insider sales without reported open-market purchases during the past six months. Aehr insider share sale Aehr Test Systems Stock Up 10.3% AEHR opened at $129.23 on Thursday. Aehr Test Systems has a twelve month low of $16.38 and a twelve month high of $133.35. The company’s 50-day moving average price is $91.98 and its two-hundred day moving average price is $70.33. The stock has a market cap of $4.22 billion, a price-to-earnings ratio of -538.44 and a beta of 3.10.
Insider Buying and Selling at Aehr Test Systems In other news, Director Howard T. Slayen sold 20,000 shares of Aehr Test Systems stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $108.30, for a total value of $2,166,000.00. Following the completion of the transaction, the director owned 146,367 shares in the company, valued at $15,851,546.10. This trade represents a 12.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Alistair N. Sporck sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $100.96, for a total transaction of $201,920.00. Following the completion of the sale, the vice president directly owned 23,547 shares in the company, valued at approximately $2,377,305.12. This trade represents a 7.83% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 23,000 shares of company stock valued at $2,476,410 in the last quarter. 6.80% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades A number of research firms recently commented on AEHR. Weiss Ratings lowered Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a research report on Wednesday, July 29th. Craig Hallum reissued a “buy” rating and set a $125.00 price target on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Lake Street Capital restated a “buy” rating and set a $110.00 price target on shares of Aehr Test Systems in a report on Wednesday, July 15th. Freedom Capital raised shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 16th. Finally, Zacks Research upgraded shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 17th. Two analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $117.50.
Get Our Latest Research Report on Aehr Test Systems
Aehr Test Systems Profile (Free Report)
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Featured Articles Five stocks we like better than Aehr Test Systems GE Vernova’s AI Power Boom Faces a Profit Test Cardinal Health Earnings: Can Perfection Get Priced In Twice? Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEDimensional Fund Advisors LP Purchases 470,968 Shares of Larimar Therapeutics, Inc. $LRMR
NEXT HEADLINE »Dimensional Fund Advisors LP Increases Stake in Hagerty, Inc. $HGTY
Key Takeaways Aehr Test Systems enters fiscal 2027 with record bookings and an effective backlog near $100.6M.AI processors, silicon photonics and power devices are driving demand for AEHR's test systems.AEHR trades at 24.62X forward sales, well above its industry average of 6.32X. Over the past month, Aehr Test Systems, Inc. (AEHR - Free Report) has surged 72.2%, easily beating the broader industry, which has gained 7.4%. The S&P 500 has risen 2.9% over the same period. Among comparable stocks, Teradyne, Inc. (TER - Free Report) has advanced 11.3%, while Cohu, Inc. (COHU - Free Report) has been flat.
The rally reflects a change in how investors view AEHR’s growth prospects. Record fourth-quarter fiscal 2026 bookings of $60.7 million and an effective backlog of about $100.6 million gave the market greater confidence in demand. The company expects significant fiscal 2027 revenue growth, supported by rising demand for semiconductor test and burn-in systems used in AI processors, silicon photonics and power devices.
AEHR One-Month Price Performance Comparison Image Source: Zacks Investment Research
The expanding order pipeline is also improving revenue visibility, as AEHR moves several customer programs toward production. Together, the strong order momentum, substantial backlog and exposure to fast-growing AI and data-center applications are driving the stock higher.
Estimates for AEHR Signal Continued GrowthFor fiscal 2027, the Zacks Consensus Estimate for Aehr Test Systems’ EPS is projected at 70 cents, a sharp increase from 3 cents a year ago. For fiscal 2028, the estimate is pegged at $1.54, indicating another 120% increase. Moreover, analysts project fiscal 2027 revenues of $140.20 million, up 180.4%, followed by $215.65 million in fiscal 2028, implying another 53.8% increase.
AEHR has topped earnings estimates in three of the past four quarters and met once, delivering an average earnings surprise of 321.9%.
AI Leads a Broadening Growth StoryAEHR is currently benefiting from several overlapping growth drivers, with AI-related semiconductor testing emerging as the most important. Its lead hyperscale customer is ramping AI processors and increasing its need for the company’s wafer-level and package-level burn-in systems. Management expects this customer’s system purchases and WaferPak requirements to increase significantly over the next several years.
Silicon photonics is becoming a major new opportunity as AI data centers increasingly use optical I/O and high-speed interconnects. Aehr already has a lead silicon-photonics customer ramping production and a newer major networking customer forecasting additional systems for hyperscale deployments. In early August, the company received a follow-on production order from its lead silicon photonics customer for a fully automated FOX-XP multi-wafer burn-in system, scheduled to ship in the first half of 2027.
Recovery in silicon carbide, particularly for EVs, is another growth avenue, which provides diversification benefits. Aehr received more than $8 million of SiC orders in the month before its July results, including orders connected to automotive programs. Management also expects renewed GaN and SiC demand from AI data-center power infrastructure.
Aehr is pursuing wafer-level burn-in opportunities in memory, including NAND flash and potential high-bandwidth memory (HBM) applications. The company is working with multiple memory suppliers as they prepare additional capacity.
Cash Gives AEHR Room to GrowAEHR's balance sheet provides a solid financial cushion, with cash and cash equivalents rising to $116.4 million as of May 29, 2026. The sizable cash position, bolstered by a public equity offering, should give the company flexibility to support capacity expansion and working-capital needs as it prepares for rapid growth in fiscal 2027.
Growth Comes at a Steep PriceThe market is already assigning AEHR a premium for its growth potential. The stock currently trades at 24.62X forward sales, above the industry average of 6.32X and its three-year median multiple of 6.05X. That premium leaves less room for disappointment.
For comparison, Teradyne trades at 10.50X forward sales, while Cohu trades at 3.61X.
Image Source: Zacks Investment Research
Risks Investors Should WatchAEHR’s biggest challenge is turning its opportunity into consistent financial results. The company depends on a relatively small group of large customers, with its lead hyperscale AI customer playing an especially important role. Delays in production ramps or changes in customer spending could make results volatile.
AEHR's business remains exposed to the capital-spending cycles of semiconductor manufacturers. Even though AI is creating strong demand, spending can be lumpy, and customer orders can shift between quarters.
Execution against elevated expectations remains a key risk. AEHR has an impressive backlog and significant AI opportunities, but the stock’s sharp run-up has raised the bar for future results. Investors will now want to see that the backlog translates into sustained revenue and earnings growth while AEHR simultaneously ramps manufacturing capacity.
Our Call: Buy AEHR Stock NowAehr Test Systems is entering fiscal 2027 with strong momentum, supported by record bookings, a sizable backlog and growing demand from AI, silicon photonics and power semiconductor markets. The sharp rise in earnings and revenue estimates further strengthens the growth case.
However, AEHR’s premium valuation and reliance on a limited number of large customers leave little room for execution missteps. Investors will be watching how quickly the company converts its backlog into revenues while expanding capacity to meet demand. Despite these risks, the strong growth outlook and favorable estimate trends support a Zacks Rank #1 (Strong Buy) for AEHR, reflecting an attractive near-term setup. You can see the complete list of today’s Zacks #1 Rank stocks here.
Lead AI processor customer expands production capacity as Aehr sees increasing interest in wafer-level burn-in for advanced AI and high-performance computing devices
FREMONT, CA / ACCESS Newswire / August 12, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced a $22 million follow-on production order from its lead wafer-level AI processor customer. The customer is a leading provider of advanced AI training and inference processors.
The order supports the customer's continued expansion of production capacity utilizing Aehr's wafer-level burn-in (WLBI) systems and includes multiple fully automated FOX-XP™ WLBI systems, together with Aehr's proprietary FOX WaferPak™ full-wafer Contactors and integrated FOX WaferPak Auto Aligners™. Each FOX-XP system is configured to test and burn in nine 300 mm wafers simultaneously. Aehr expects to ship the systems over the next six months for installation at the customer's high-volume manufacturing partner in Taiwan.
"This $22 million follow-on order represents another significant expansion of WLBI capacity by our lead AI processor customer and further validates the use of our FOX-XP platform in high-volume production," said Gayn Erickson, President and Chief Executive Officer of Aehr Test Systems. "We are encouraged that the customer's current production plans contemplate capacity beyond this order and that we continue to engage with additional semiconductor companies and hyperscalers following positive wafer-level benchmark results.
"We believe this growing interest is being driven in part by the increasing value and complexity of advanced AI semiconductor packages. As AI devices incorporate increasingly valuable processors, high-bandwidth memory (HBM), interface logic, and other die in advanced packages, screening for early-life failures before final assembly can deliver significant quality and economic benefits. We believe these trends are expanding the market opportunity for wafer-level burn-in across AI accelerators, CPUs, network processors and other high-performance computing and semiconductor memory devices."
Aehr's FOX-XP platform enables high-volume WLBI and test before semiconductor devices are singulated and packaged. Each FOX-XP system can simultaneously burn in and test up to nine 300 mm wafers and can be integrated with Aehr's FOX WaferPak Auto Aligner for automated operation in high-volume manufacturing environments.
Aehr's FOX WLBI systems and proprietary WaferPak contactors help identify early-life and latent reliability failures before devices are singulated and incorporated into advanced packages, improving the quality of die entering assembly and reducing the risk of committing high-value HBM, substrates, interposers, and other components to devices that may subsequently fail reliability screening.
The company believes increasing processor performance, power, device value, advanced packaging, and HBM integration may expand the range of AI and high-performance computing applications for which WLBI provides attractive manufacturing economics.
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer-level, singulated die, and package-level form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including advanced artificial intelligence (AI) processors, silicon photonics, data and telecommunications infrastructure, electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, and solid-state memory and storage are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr's products and solutions. Aehr has developed and introduced several innovative products including the FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full-wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full-wafer contactor capable of testing wafers up to 300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. Acquired through its acquisition of Incal Technology, Inc., Aehr's new line of high-power package-level reliability/burn-in test solutions for AI semiconductor manufacturers, including its ultra-high-power Sonoma family of test solutions for AI accelerators, GPUs, and high-performance computing (HPC) processors, position Aehr within the rapidly growing AI market as a turnkey provider of reliability and testing that span from engineering to high volume production. For more information, please visit Aehr Test Systems' website at www.aehr.com.
Safe Harbor Statement
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr's future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "going to," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," or "continue," or the negative of these words or other similar terms or expressions that concern Aehr's expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, future requirements and orders of Aehr's new and existing customers; Aehr's ability to receive orders and generate revenue in the future, as well as Aehr's beliefs regarding the factors impacting the foregoing, including the growth of the markets referred to herein; Aehr's ability to integrate Incal efficiently; and the timing and extent to which the acquisition is accretive. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr's recent Form 10-K, 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.
Alistair N. Sporck, Vice President of the Contactor Business Unit at Aehr Test Systems, Inc. (AEHR +10.34%), sold 1,000 shares of common stock on August 10, 2026, according to an SEC Form 4 filing.
Transaction summaryMetricValueTransaction value$108,490Shares sold (directly held)1,000Post-transaction shares (directly held)22,547Post-transaction shares (indirectly held)5,177Post-transaction value~$2.9 millionTransaction value based on SEC Form 4 weighted average sale price ($108.49); post-transaction value based on August 10, 2026 market close ($106.20).
Key questionsHow does this sale align with the insider's total equity exposure?
The transaction was a modest liquidity event, as Alistair N. Sporck retains 97% of their total equity stake, including both direct ownership and shares held via trust.Are there specific conditions attached to the remaining shares?
Direct holdings reported in this filing include shares subject to unvested restricted stock units, ensuring continued long-term alignment with the company's performance.How does the transaction price compare to recent market levels?
The execution at $108.49 per share occurred at a slight premium to the $106.20 market close on the day of the transaction.Company OverviewMetricValueShare Price (as of market close 2026-08-10)$106.20Market Capitalization$3.5 billionRevenue (TTM)$50.9 millionNet Income (TTM)-$7.1 millionCompany SnapshotAehr Test Systems designs and manufactures advanced burn-in and test systems for integrated circuits, including logic, optical, and memory devices, with principal product families comprising the ABTS and FOX-P systems alongside specialized components such as the FOX WaferPak Aligner and FOX DiePak Carrier.The company generates revenue through the sale of proprietary test and burn-in equipment to semiconductor manufacturers and foundries, supplemented by recurring revenue from service, maintenance, and consumable components associated with its installed equipment base.Aehr Test Systems serves global semiconductor manufacturers, foundries, and integrated device manufacturers requiring advanced thermal and electrical testing solutions for high-reliability integrated circuit validation and production.Aehr Test Systems, founded in 1977 and headquartered in Fremont, California, is a specialized provider of mission-critical test and burn-in systems serving the global semiconductor industry. The company maintains a focused operational footprint with 138 employees while generating $50.9 million in trailing twelve-month revenue, reflecting its position as a niche supplier of high-value equipment to semiconductor manufacturers.
With a market cap of $3.5 billion and significant recent appreciation, Aehr Test Systems represents a capital-efficient business model dependent on technological differentiation and customer concentration within the semiconductor equipment sector.
What this transaction means for investorsVP Alistair Sporck’s Aug. 10 sale of Aehr Test Systems stock occurred after shares attained a 484% one-year total return. It appears Sporck was capitalizing on the price increase to capture gains.
That said, the disposition only comprised a modest 3% of Sporck’s total equity position. Post-transaction holdings of over 27,000 suggest the insider maintains continued alignment with shareholder interests.
Aehr Test Systems is up thanks to an outstanding earnings report for its fiscal fourth quarter ended May 29. Revenue rose to $18.8 million, up from $14.1 million in the prior year. This demonstrates the growing customer demand the company is seeing for its semiconductor testing capabilities as a result of the rapidly expanding artificial intelligence sector.
Its growing revenue enabled the company to achieve fiscal Q4 net income of $1.4 million, an impressive reversal from the prior year’s net loss of $2.9 million. For its 2027 fiscal year, Aehr forecasted approximately 160% to 200% year-over-year sales growth. The astounding increase in net income and the next fiscal year’s revenue also contributed to the stock’s rise.
Robert Izquierdo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Shares of Aehr Test Systems (NASDAQ:AEHR) are up 6.1% in midday trading Tuesday, extending a torrid summer run in the semiconductor test equipment name. The stock now trades near $116, closing in on its 52-week high of $126.62 after a fresh wave of buying tied to the company’s AI burn-in and silicon photonics story.
Earnings Momentum Keeps Fueling the Rally The move builds on a blowout fiscal Q4 report. Aehr delivered Q4 revenue of $18.84 million, swung back to profitability with net income of $1.39 million, and posted EPS of $0.11 against expectations for a narrow gain. Record Q4 bookings of $60.7 million pushed effective backlog to $100.6 million, giving the company visibility into a much larger fiscal 2027.
Management’s forward outlook is what changed the stock’s ceiling. Aehr guided fiscal 2027 revenue to $130 million to $150 million, implying 160% to 200% year-over-year growth. CEO Gayn Erickson has been clear about the driver: “We are very pleased with the strong momentum in our business across multiple market segments, highlighted by more than $37 million in quarterly bookings and a book-to-bill ratio exceeding 3.5x.” AI processors and silicon photonics testing together accounted for 91% of Q4 revenue, a dramatic mix shift from the silicon carbide-heavy business investors bought two years ago.
The Silicon Photonics Whipsaw Here is where the story gets more complicated, and why the stock has been so volatile. Aehr is now one of the purest public plays on optical interconnects for hyperscale AI, a corner of the market that has been swinging on every headline. On August 4, Aehr announced a follow-on production order from its lead silicon photonics customer for a fully automated FOX-XP multi-wafer system with nine independent WaferPak test blades, expected to ship in the first half of 2027. Erickson framed the order as evidence that silicon photonics is moving “from technology adoption to manufacturing scale-up.”
That announcement sent shares up 57% in the days that followed, and the stock is now up 15.8% over the past week and 46% over the past month. Year to date, AEHR is up an eye-watering 426%. But optical and photonics names have traded in violent back-and-forth patterns all summer, whipsawing on hyperscaler capex commentary, competitive positioning, and shifting expectations for co-packaged optics timelines. With a beta of 3.1, Aehr amplifies every move in the group.
Valuation and Positioning Cut Both Ways The bull case is that backlog now covers roughly 77% of the minimum fiscal 2027 guidance, and while Aehr is expensive, it also has several new ramping markets into the future and has displayed strong recent execution. The bear case has teeth too. The company trades at a price-to-sales ratio of 69. Insiders have been trimming into strength: director Howard T. Slayen sold 20,000 shares at $108.30 on August 4, and Aehr filed an omnibus shelf registration on July 31, signaling flexibility to raise capital.
Wall Street coverage remains constructive. The analyst target price sits at $115, with three buy ratings and one hold. That target is essentially at the stock, meaning further upside now depends on estimates catching up to the fiscal 2027 ramp.
Contact [email protected] for any questions or corrections.
Howard T. Slayen, a member of the Board of Directors at Aehr Test Systems, Inc. (AEHR -6.97%), sold 20,000 shares of common stock on August 4, 2026, according to an SEC Form 4 filing.
Transaction summaryMetricValueTransaction value$2.2 millionShares sold20,000Post-transaction shares (directly held)146,367Post-transaction value$16.08 millionTransaction value based on SEC Form 4 weighted average sale price ($108.30); post-transaction value based on August 4, 2026 market close ($109.89).
Key questionsHow did this transaction affect the director's total equity exposure?
The sale of 20,000 shares reduced Howard Slayen's direct equity interest by 12%, leaving a remaining direct position of ~146,000 shares.At what valuation was the equity disposed of relative to the trade-date close?
The shares were sold at a weighted average price of $108.30 per share, while the stock was priced at $109.89 at the August 4, 2026 market close.Are there specific conditions attached to the remaining shares?
The director's remaining direct holdings include shares subject to unvested restricted stock units (RSUs), which ensures a portion of his equity compensation remains subject to future vesting requirements.Company OverviewMetricValueShare Price (as of market close 2026-08-04)$109.89Market Capitalization$3.6 billionRevenue (TTM)$50.9 millionNet Income (TTM)($7.1 million)Company SnapshotAehr Test Systems designs and manufactures advanced burn-in and test systems for integrated circuits, including logic, optical, and memory devices, with a comprehensive product portfolio featuring the ABTS and FOX-P families of solutions.The company generates revenue through the sale of specialized semiconductor test and burn-in equipment, along with complementary components such as WaferPak aligners, contactors, and carriers that support its core testing platforms.Aehr serves semiconductor manufacturers and integrated device manufacturers globally who require advanced testing and burn-in capabilities to validate the reliability and performance of their integrated circuit products.Aehr Test Systems, founded in 1977 and headquartered in Fremont, California, is a specialized provider of advanced burn-in and test solutions for the semiconductor industry. With a market cap of $3.6 billion, the company has demonstrated significant market momentum, with a one-year share price appreciation of 477.46%.
The company's focused product portfolio and specialized expertise in semiconductor testing position it as a critical supplier to manufacturers requiring advanced validation and reliability assessment capabilities for integrated circuits.
What this transaction means for investorsDirector Howard Slayen is yet another Aehr Test Systems insider selling after the stock ran up nearly 500% in the past 12 months. His August 4 disposition was a discretionary transaction, which makes sense given the significant share price increase.
The sale reduced holdings by a substantial 12%. That said, Slayen retained over 146,000 shares post-transaction, some of which are unvested RSUs, limiting his ability to dispose of more stock until they vest. This helps to ensure his continued alignment with shareholder interests.
Aehr Test Systems stock rose thanks to a strong earnings report for its fiscal fourth quarter ended May 29. Revenue reached $18.8 million, up from $14.1 million in the prior year.
In addition, the company announced record fiscal Q4 bookings of $60.7 million, and forecasted sales between $130 million and $150 million in its 2027 fiscal year. That’s a massive increase from the $50 million made in fiscal 2026, and sign customer demand is accelerating amid growth in the artificial intelligence sector.
Slayen is a long-time Board member, having served with Aehr Test Systems since 2008.
Robert Izquierdo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Geoffrey Gates Scott, a Director at Aehr Test Systems, Inc. (AEHR +19.82%), reported the disposition of 30,000 shares of common stock on July 16, 2026. SEC Form 4 filing
Transaction summaryMetricValueTransaction value$2.5 millionShares sold (indirectly held)30,000Post-transaction shares (directly held)54,522Post-transaction shares (indirectly held)60,686Post-transaction value$9.70 millionTransaction value based on SEC Form 4 weighted average sale price ($82.13); post-transaction value based on July 16, 2026 market close ($84.20).
Key questionsWhat was the nature of the indirect dispositions?
The transaction comprised a sale of 20,000 shares held by a spouse and a charitable gift of 10,000 shares to the Scott Family Fund.How does this impact the director's total stake?
Following these transactions, Geoffrey Gates Scott retains ~115,000 total shares, which includes 54,522 shares held directly and 60,686 shares held indirectly through a trust and a spouse.What is the valuation context for the reported activity?
The 20,000 shares were sold at a weighted average price of $82.13 per share, while the underlying stock was priced at $84.20 at the July 16, 2026 market close.Does the insider hold additional equity incentives?
The reported direct holdings include shares subject to unvested restricted stock units, and the director also holds derivative securities.Company OverviewMetricValueShare Price (as of market close 2026-07-16)$84.20Market Capitalization$2.5 billionRevenue (TTM)$50.9 millionNet Income (TTM)-$7.1 millionCompany SnapshotAehr Test Systems designs and manufactures advanced burn-in and test systems for integrated circuits, including logic, optical, and memory devices, with core products comprising the ABTS and FOX-P families of test and burn-in solutions.The company generates revenue through the sale of specialized semiconductor testing equipment and complementary components such as WaferPak aligners, contactors, and carriers, serving as a critical supplier in the semiconductor manufacturing and validation process.The company primarily serves semiconductor manufacturers and integrated device manufacturers (IDMs) that require advanced testing and burn-in capabilities to ensure product reliability and performance across diverse device categories.Aehr Test Systems, founded in 1977 and headquartered in Fremont, California, is a specialized provider of semiconductor test and burn-in equipment with a market cap of $2.5 billion. The company has demonstrated significant market momentum, with share price appreciation of 469.69% over the past twelve months, reflecting growing demand for advanced semiconductor testing solutions.
With 136 employees and trailing 12-month revenues of $50.9 million, Aehr operates in the capital-intensive semiconductor equipment sector, positioning itself as a niche player serving critical validation requirements in the semiconductor manufacturing ecosystem.
What this transaction means for investorsThe July 16 sale of Aehr Test Systems stock did not involve a disposition by Board of Directors member Geoffrey Scott. Rather, his spouse sold 20,000 shares. Another 10,000 shares were gifted to the Scott Family Fund.
Scott’s spouse holds 30,000 shares after the sale, which means the disposition reduced holdings by a substantial 40%. This is a significant reduction, and came after shares soared 470% over the past 12 months.
That said, the stock price has gone up since this sale, exceeding $100 per share as of August 4. Aehr Test Systems stock rose due to strong performance in its fiscal fourth quarter ended May 29. Revenue reached $18.8 million, compared to $14.1 million in the previous year. Sales are up as a result of increased demand from semiconductor chip manufacturers amid the rise of artificial intelligence.
Geoffrey Scott retains over 54,000 shares after the July 16 transaction, with some of these comprising unvested restricted stock units (RSUs). The RSUs will have to vest before they are eligible to be sold, ensuring continued alignment with shareholder interests.
Microsoft: Steady Revenue ExpansionMicrosoft (MSFT +1.06%) primarily generates revenue by licensing software applications, providing cloud computing services, and selling computing and gaming hardware to diverse global enterprise and consumer customers.
It recently formed a strategic partnership with Databricks to integrate business contexts into enterprise models and reported a 40% net income margin for the quarter ended June 30, 2026. The company simultaneously navigated multiple class action lawsuits regarding historical performance disclosures.
Aehr Test Systems: Navigating Extreme Revenue FluctuationsAehr Test Systems (AEHR +19.82%) primarily generates revenue by designing and providing advanced burn-in and testing systems that help global manufacturers verify the reliability of complex integrated circuits.
While experiencing no major adverse events, it recently secured follow-on orders for its fully automated wafer-level burn-in systems and reported a 41% gross margin for the quarter ended May 29, 2026.
Why Revenue Matters for Retail InvestorsRevenue serves as a crucial baseline metric for investors to track business volume and customer demand over time. This metric helps investors measure a company’s overall size, market footprint, and long-term trajectory.
Quarterly Revenue for Microsoft and Aehr Test SystemsQuarter (Period End)Microsoft RevenueAehr Test Systems RevenueQ3 2024$65.6 billion (period ended Sept. 2024)$13.1 million (period ended Aug. 2024)Q4 2024$69.6 billion (period ended Dec. 2024)$13.5 million (period ended Nov. 2024)Q1 2025$70.1 billion (period ended March 2025)$18.3 million (period ended Feb. 2025)Q2 2025$76.4 billion (period ended June 2025)$14.1 million (period ended May 2025)Q3 2025$77.7 billion (period ended Sept. 2025)$11.0 million (period ended Aug. 2025)Q4 2025$81.3 billion (period ended Dec. 2025)$9.9 million (period ended Nov. 2025)Q1 2026$82.9 billion (period ended March 2026)$10.3 million (period ended Feb. 2026)Q2 2026$90.0 billion (period ended June 2026)$18.8 million (period ended May 2026)Data source: Company filings. Data as of July 31, 2026.
Foolish TakeComparing revenue trends between Microsoft and Aehr Test Systems provides revealing insights. The former’s consistent quarter-over-quarter sales growth is a testament to the strength of its offerings as it successfully captures AI customer demand.
Aehr Test Systems experienced volatile swings in sales over the past several quarters, as its role in testing for the semiconductor industry does not lend itself to the kind of consistent revenue growth seen with Microsoft. However, its most recent quarter’s revenue of $18.8 million, along with record bookings of $60.7 million, indicate customer demand is heating up as the artificial intelligence sector continues to expand. Consequently, Aehr Test Systems stock edged past $100, up over 400% in 2026 through August 4.
Microsoft shares hit a 52-week low of $349.20 in June, as its spending on AI infrastructure spooked Wall Street. Shares rebounded after the company posted earnings results for its fiscal fourth quarter ended June 30. Despite the spending on AI, Microsoft delivered diluted earnings per share of $4.81, a substantial increase from $3.65 in the previous year. This demonstrates the tech titan can invest in infrastructure and continue to grow profits.
The move also lines up with a risk-on session in growth, with the Nasdaq up 2.27% as markets stay open.
• Aehr Test System shares are climbing with conviction. Why is AEHR stock up today?
Order Supports Production ExpansionThe customer will use the automated multi-wafer burn-in system to expand silicon photonic integrated circuit production.
The circuits support optical transceivers and chip-to-chip optical input/output applications.
The system includes nine WaferPak test blades, each delivering up to 3,500 watts, plus automated alignment, handling, loading and unloading.
Aehr expects shipment during the first half of 2027.
AI Demand Drives OpportunityAehr said rising AI infrastructure demand is expanding silicon photonics use across optical switching, co-packaged optics and linear pluggable optics.
Wafer-level burn-in can identify defects before packaging, improve yields, lower costs and support long-term reliability.
"This production order is another indication that silicon photonics is moving from technology adoption into manufacturing scale-up, and we believe that transition represents a significant long-term growth opportunity for Aehr," CEO Gayn Erickson said.
The FOX-XP platform supports burn-in and reliability screening for silicon photonics, silicon carbide semiconductors, AI processors and other advanced devices.
AEHR Technical Outlook: Momentum and Key Chart LevelsAEHR is trading 25.7% above its 20-day SMA of $80.33 and 87.8% above its 200-day SMA of $53.77. That keeps the long-term uptrend intact, though the stock appears stretched after its recent advance.
The 20-day SMA remains below the 50-day SMA, a bearish crossover that suggests bulls may need the stock to hold recent gains before shorter-term averages turn higher.
Momentum is improving, with MACD above its signal line and the histogram in positive territory. That indicates buyers are regaining control and downside pressure is easing.
Traders may watch whether AEHR can consolidate above prior breakout levels. The 52-week high of $126.62 remains overhead, while the June swing high could also act as resistance.
Key Resistance: $110 — Nearby round-number level where rebounds may stall. Key Support: $84.50 — Near the 20-day EMA of $83.56 and a potential trend-support zone. AEHR Stock Price Activity: Aehr Test System shares were up 16.84% at $107.15 at the time of publication on Tuesday, according to Benzinga Pro data.
Photo: Pavel Kapysh / Shutterstock.com
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
FREMONT, CA / ACCESS Newswire / August 4, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced it has received a follow-on production order from its lead silicon photonics wafer-level burn-in (WLBI) customer for a fully automated FOX-XP® multi-wafer production burn-in system to support the continued expansion of the customer's manufacturing capacity for next-generation silicon photonic integrated circuits.
The AI industry is rapidly transitioning from moving electrons to moving photons, driving a significant expansion in silicon photonics as hyperscale data centers seek higher bandwidth, lower latency, improved power efficiency, and greater scalability. As silicon photonic integrated circuits become increasingly critical to next-generation AI networking, optical switching, co-packaged optics, linear pluggable optics, and chip-to-chip optical I/O architectures, manufacturers are placing greater emphasis on production-scale reliability screening and WLBI to ensure long-term performance while improving manufacturing yields and reducing production costs.
The ordered system is configured with nine independent WaferPak® test blades, each capable of delivering up to 3,500 watts of power for production burn-in and reliability screening of high-performance silicon photonic integrated circuits used in optical transceivers and emerging chip-to-chip optical I/O applications. The system also includes Aehr's fully integrated automated wafer-level handling solution, consisting of the FOX-XP multi-wafer production burn-in system, integrated WaferPak Auto Aligner™, robotic wafer handling, and automated wafer loading and unloading, providing a complete high-volume automated WLBI solution.
The system is expected to ship during the first half of calendar 2027.
Gayn Erickson, President and Chief Executive Officer of Aehr Test Systems, commented:
"This production order is another indication that silicon photonics is moving from technology adoption into manufacturing scale-up, and we believe that transition represents a significant long-term growth opportunity for Aehr. The order reflects our lead silicon photonics customer's continued expansion of manufacturing capacity and represents another important milestone in the industry's transition toward high-volume production of silicon photonic integrated circuits.
"As AI clusters continue to grow in size and performance, silicon photonics is emerging as a key enabling technology for delivering the bandwidth, power efficiency, and scalability required by next-generation AI infrastructure. What began with optical transceivers is now expanding into optical switching, co-packaged optics, linear pluggable optics, and chip-to-chip optical I/O.
"At the same time, the industry is moving toward more highly-integrated optical architectures that integrate or closely co-package laser sources with silicon photonic integrated circuits. These advances improve performance, reduce system cost, simplify manufacturing, and make device reliability even more critical.
"As silicon photonic devices continue to increase in complexity, power density, and production volumes, we believe WLBI is becoming a foundational manufacturing step for many of these next-generation devices. Identifying latent defects and stabilization of the integrated lasers before packaging improves manufacturing yields, lowers overall production costs, and enables the long-term reliability demanded by hyperscale AI infrastructure.
"Over the past year, we've seen a meaningful increase in engagement from silicon photonics companies around the world spanning engineering qualification systems, production capacity planning, and next-generation device roadmaps. These discussions reinforce our belief that the market is approaching an important inflection point.
"As production requirements evolve toward higher power, fully-automated wafer-level manufacturing, and larger production volumes, we believe our FOX-XP platform and integrated automated wafer-level handling solution position Aehr to become the production standard for wafer-level reliability screening of silicon photonic integrated circuits."
Industry analysts project strong growth for silicon photonics through the remainder of the decade as hyperscale AI infrastructure, cloud computing, high-performance computing, and advanced optical networking continue driving demand for higher bandwidth and lower power interconnect technologies. Emerging applications including co-packaged optics, optical switching, linear pluggable optics, and chip-to-chip optical I/O are expected to further expand the adoption of silicon photonics throughout AI infrastructure. Industry research also points to increasing adoption of integrated and co-packaged laser architectures that improve optical performance, manufacturing scalability, and system efficiency while further increasing the importance of production reliability screening.
Aehr's FOX-XP multi-wafer production burn-In system performs full WLBI, stability testing, and production screening of semiconductor devices while enabling customers to test multiple wafers simultaneously in a highly automated manufacturing environment. The FOX-XP platform supports silicon photonics, silicon carbide power semiconductors, AI processors, optical devices, and other semiconductor products requiring production burn-in and reliability screening.
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer-level, singulated die, and package-level form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including advanced artificial intelligence (AI) processors, silicon photonics, data and telecommunications infrastructure, electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, and solid-state memory and storage are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr's products and solutions. Aehr has developed and introduced several innovative products including the FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full-wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full-wafer contactor capable of testing wafers up to 300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. Acquired through its acquisition of Incal Technology, Inc., Aehr's new line of high-power package-level reliability/burn-in test solutions for AI semiconductor manufacturers, including its ultra-high-power Sonoma family of test solutions for AI accelerators, GPUs, and high-performance computing (HPC) processors, position Aehr within the rapidly growing AI market as a turnkey provider of reliability and testing that span from engineering to high volume production. For more information, please visit Aehr Test Systems' website at www.aehr.com.
Safe Harbor Statement
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr's future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "going to," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," or "continue," or the negative of these words or other similar terms or expressions that concern Aehr's expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, future requirements and orders of Aehr's new and existing customers; Aehr's ability to receive orders and generate revenue in the future, as well as Aehr's beliefs regarding the factors impacting the foregoing, including the growth of the markets referred to herein; Aehr's ability to integrate Incal efficiently; and the timing and extent to which the acquisition is accretive. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr's recent Form 10-K, 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.
Aehr Test Systems (AEHR +4.05%) and C3.ai (AI +1.21%) both aim to capitalize on the artificial intelligence boom, but they operate on opposite ends of the technological spectrum. Which is the better buy?
Aehr focuses on the hardware side, providing essential testing equipment for chips used in high-growth markets like electric vehicles and data centers. C3.ai provides the software layer, helping massive organizations deploy predictive artificial intelligence applications. Both companies are navigating a shifting landscape where rapid innovation meets lumpy revenue cycles.
The case for Aehr Test SystemsAehr Test Systems designs and sells specialized equipment used to test chips at the wafer level to identify defects before they reach final assembly. The company is a niche player among semiconductor stocks, providing essential testing equipment for silicon carbide chips. Customer concentration like this adds a layer of risk to the business, as its five largest customers accounted for roughly 70% of net revenues in fiscal 2026.
In FY 2026, revenue reached close to $50.0 million, representing a decline of approximately 15.2% compared to the previous year. This revenue drop contributed to a net loss of roughly $7.1 million for the period. The net margin, which shows how much of each dollar earned becomes profit after all expenses, was nearly -14.3%.
As of its May 2026 balance sheet, the company maintains a current ratio of approximately 10.3x. The current ratio measures a firm's ability to cover short-term debts with short-term assets, with a higher number generally suggesting better liquidity. The debt-to-equity ratio is roughly 0.0x, indicating the company holds negligible debt relative to its shareholder equity while free cash flow was nearly -$5.4 million.
The case for C3.aiC3.ai builds enterprise software that allows large organizations to develop and run artificial intelligence applications at scale. The company focuses on industries with complex data needs, such as oil and gas, defense, and manufacturing, through partnerships with Baker Hughes and Shell. It is currently transitioning toward a consumption-based pricing model to attract more customers and improve long-term adoption.
In FY 2026, revenue reached approximately $250.3 million, which is a decline of nearly 35.7% from the prior year. This lower top-line performance resulted in a net loss of close to $470.4 million. The net margin for the fiscal year was roughly -187.9%, suggesting that expenses significantly outpaced revenue during this period of business transformation.
As of the April 2026 balance sheet, the current ratio stands at approximately 6.6x. The debt-to-equity ratio is roughly 0.0x, meaning the company has a clean balance sheet with no significant debt compared to equity. Free cash flow for the year was nearly -$190.7 million, reflecting the cash used by the business for operations and capital investments after subtracting essential spending.
Risk profile comparisonAehr faces high revenue concentration, meaning the loss of a single major client could severely hurt the business. It also navigates intense competition from larger rivals with more resources in the chip-testing market. Rapid technological shifts could make its current systems obsolete if it fails to innovate quickly, and geopolitical tensions in China and Taiwan present risks to its global supply chain.
C3.ai has a history of significant net losses and persistent operating deficits with no clear path to immediate profitability. The company faces stiff competition from major cloud providers like Microsoft, Amazon, and Alphabet. Revenue is heavily dependent on a few high-value contracts, and evolving regulations such as the EU AI Act could introduce new compliance hurdles for its software platform.
Valuation comparisonC3.ai carries a lower P/S ratio than its peer, though C3.ai does not currently have a meaningful or positive forward P/E ratio because the company is projected to log net losses through fiscal year 2027.
MetricAehr Test SystemsC3.aiForward P/E127.7xN/AP/S ratio52.5x5.6xValuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
I'd go with Aehr Test Systems, and it's not close. C3.ai's own CEO described recent sales performance as "unspeakably horrible" and "surreal.” That’s not exactly the language you want to hear from a company trying to convince investors that the worst is behind it. Revenue has fallen sharply, and the company has cut roughly a third of its workforce. Analysts expect further declines ahead. A top-to-bottom sales reorganization is underway and may eventually pay off, but right now this company is struggling.
Aehr Test Systems is running a tighter, more focused operation and delivering results that back it up. The company just reported record quarterly bookings, a record backlog, and guided for revenue growth of roughly two to three times its current level in the coming fiscal year. Its burn-in testing equipment is becoming increasingly critical as AI chip complexity grows, and demand is accelerating across AI processors, silicon photonics, and power semiconductors.
For a long-term investor, Aehr offers a clear growth trajectory backed by a record backlog. C3.ai is still trying to find its footing.
Investors might want to bet on Aehr Test Systems (AEHR - Free Report) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.
Analysts' growing optimism on the earnings prospects of this company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.
The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.
Consensus earnings estimates for the next quarter and full year have moved considerably higher for Aehr Test Systems, as there has been strong agreement among the covering analysts in raising estimates.
The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:
12 Month EPS
Current-Quarter Estimate RevisionsThe company is expected to earn $0.10 per share for the current quarter, which represents a year-over-year change of +900.0%.
The Zacks Consensus Estimate for Aehr Test Systems has increased 150% over the last 30 days, as one estimate has gone higher compared to no negative revisions.
Current-Year Estimate RevisionsFor the full year, the earnings estimate of $0.70 per share represents a change of +2,233.3% from the year-ago number.
In terms of estimate revisions, the trend for the current year also appears quite encouraging for Aehr Test Systems. Over the past month, one estimate has moved higher compared to no negative revisions, helping the consensus estimate increase 1350%.
Favorable Zacks RankThanks to promising estimate revisions, Aehr Test Systems currently carries a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.
Bottom LineAehr Test Systems shares have added 9.9% over the past four weeks, suggesting that investors are betting on its impressive estimate revisions. So, you may consider adding it to your portfolio right away to benefit from its earnings growth prospects.
Shares of Aehr Test Systems (AEHR - Free Report) have gained 9.9% over the past four weeks to close the last trading session at $76.87, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $115 indicates a potential upside of 49.6%.
The mean estimate comprises three short-term price targets with a standard deviation of $8.66. While the lowest estimate of $110.00 indicates a 43.1% increase from the current price level, the most optimistic analyst expects the stock to surge 62.6% to reach $125.00. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.
While the consensus price target is highly sought after by investors, the ability and unbiasedness of analysts in setting price targets have long been questionable. And investors making investment decisions solely based on this tool would arguably do themselves a disservice.
But, for AEHR, an impressive average price target is not the only indicator of a potential upside. Strong agreement among analysts about the company's ability to report better earnings than they predicted earlier strengthens this view. While a positive trend in earnings estimate revisions doesn't gauge how much a stock could gain, it has proven to be powerful in predicting an upside.
Price, Consensus and EPS Surprise
Here's What You Should Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.
While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?
They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.
However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.
That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism.
Why AEHR Could Witness a Solid UpsideAnalysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason to expect an upside in the stock. That's because empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For the current year, one estimate has moved higher over the last 30 days compared to no negative revision. As a result, the Zacks Consensus Estimate has increased 1350%.
Moreover, AEHR currently has a Zacks Rank #1 (Strong Buy), which means it is in the top 5% of more than 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Therefore, while the consensus price target may not be a reliable indicator of how much AEHR could gain, the direction of price movement it implies does appear to be a good guide.
A downtrend has been apparent in Aehr Test Systems (AEHR - Free Report) lately. While the stock has lost 18.2% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed in its last trading session. This could mean that the bulls have been able to counteract the bears to help the stock find support.
While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about the future earnings of this company is a solid fundamental factor that enhances the prospects of a trend reversal for the stock.
Understanding Hammer Chart and the Technique to Trade ItThis is one of the popular price patterns in candlestick charting. A minor difference between the opening and closing prices forms a small candle body, and a higher difference between the low of the day and the open or close forms a long lower wick (or vertical line). The length of the lower wick being at least twice the length of the real body, the candle resembles a 'hammer.'
In simple terms, during a downtrend, with bears having absolute control, a stock usually opens lower compared to the previous day's close, and again closes lower. On the day the hammer pattern is formed, maintaining the downtrend, the stock makes a new low. However, after eventually finding support at the low of the day, some amount of buying interest emerges, pushing the stock up to close the session near or slightly above its opening price.
When it occurs at the bottom of a downtrend, this pattern signals that the bears might have lost control over the price. And, the success of bulls in stopping the price from falling further indicates a potential trend reversal.
Hammer candles can occur on any timeframe -- such as one-minute, daily, weekly -- and are utilized by both short-term as well as long-term investors.
Like every technical indicator, the hammer chart pattern has its limitations. Particularly, as the strength of a hammer depends on its placement on the chart, it should always be used in conjunction with other bullish indicators.
Here's What Increases the Odds of a Turnaround for AEHRThere has been an upward trend in earnings estimate revisions for AEHR lately, which can certainly be considered a bullish indicator on the fundamental side. That's because a positive trend in earnings estimate revisions usually translates into price appreciation in the near term.
Over the last 30 days, the consensus EPS estimate for the current year has increased 1350%. What it means is that the sell-side analysts covering AEHR are majorly in agreement that the company will report better earnings than they predicted earlier.
If this is not enough, you should note that AEHR currently has a Zacks Rank #1 (Strong Buy), which means it is in the top 5% of more than 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. And stocks carrying a Zacks Rank #1 or 2 usually outperform the market. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Moreover, the Zacks Rank has proven to be an excellent timing indicator, helping investors identify precisely when a company's prospects are beginning to improve. So, for the shares of Aehr Test Systems, a Zacks Rank of 1 is a more conclusive fundamental indication of a potential turnaround.
Shares in Aehr Test Systems (AEHR -5.38%) rose 15.4% in the week to Friday morning. The reasons behind the move will have to come down to speculation, as there's no hard, fundamental news about the stock in the last week. Still, Aehr is somewhat of a proxy for the theme of investing in the growth of AI semiconductor spending, and that's probably why there's been speculative buying this week.
Why Aehr Test Systems shares rose this week As a reminder, Aehr Test Systems makes test equipment and systems that help semiconductor manufacturers ensure reliability and quality. It's also a company that has successfully transitioned its focus from the electric vehicle (EV) market to the AI processor market, in line with shifts in end demand.
Today's Change
(
-5.38
%) $
-5.03
Current Price
$
88.51
The company is known for being tight-lipped about its customers for commercial reasons and lists customers who have been responsible for at least 10% of its revenue in terms of "Customer A" to "Customer G" in its SEC filings. As such, investors are always left playing the guessing game of who its customers might be. That's a big issue, considering how small the company is, with just $50 million in revenue in its recently completed 2026 financial year. In other words, every major order (bookings were $60.7 million in the fourth quarter of 2026) is a game changer.
Image source: Getty Images.
Aehr's customers reporting? Management refers to two lead customers in its reporting. One is a leading hyperscaler developing AI processors, and the other is an AI production customer developing silicon photonics technology. Given that Alphabet's Google and Intel could fit the profile of these two unnamed customers, and that both reported this week, it's possible investors bought into Aehr in anticipation of these two companies announcing ramp-ups in capital spending that might be beneficial to Aehr.
As long as momentum continues to build toward a ramp in AI spending, then stocks like Aehr will find favor among investors, and vice versa if the market starts slowing.
Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet and Intel. The Motley Fool has a disclosure policy.
Analyst’s Disclosure: I/we have a beneficial long position in the shares of AEHR either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
The Computer and Technology group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Aehr Test Systems (AEHR - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Computer and Technology sector should help us answer this question.
Aehr Test Systems is a member of our Computer and Technology group, which includes 613 different companies and currently sits at #2 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Aehr Test Systems is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for AEHR's full-year earnings has moved 1350% higher within the past quarter. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
According to our latest data, AEHR has moved about 301.4% on a year-to-date basis. In comparison, Computer and Technology companies have returned an average of 12%. As we can see, Aehr Test Systems is performing better than its sector in the calendar year.
One other Computer and Technology stock that has outperformed the sector so far this year is Cisco Systems (CSCO - Free Report) . The stock is up 45.3% year-to-date.
In Cisco Systems' case, the consensus EPS estimate for the current year increased 3.6% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Aehr Test Systems belongs to the Electronics - Measuring Instruments industry, a group that includes 5 individual stocks and currently sits at #6 in the Zacks Industry Rank. On average, stocks in this group have gained 55.4% this year, meaning that AEHR is performing better in terms of year-to-date returns.
On the other hand, Cisco Systems belongs to the Computer - Networking industry. This 7-stock industry is currently ranked #199. The industry has moved +45.2% year to date.
Aehr Test Systems and Cisco Systems could continue their solid performance, so investors interested in Computer and Technology stocks should continue to pay close attention to these stocks.
